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SUMMARY
ALA synthase, localised within the inner mitochondrial membrane, 
has been identified as the rate limiting enzyme of hepatic haem 
biosynthesis, subject to negative feedback control by haem.
Liver, however, is a minor haem forming tissue as erythroblasts 
synthesise 85% of the total daily haem and are the cells most 
sensitive to haem deficiency. Within developing erythroid cells 
haem is required both for its specific complexing with globin and 
for the co-ordinate regulation of erythroblast metabolism and 
differentiation.
It does then seem surprising that in contrast to our understanding 
of hepatic haem biosynthesis and its regulation by ALA synthase, 
little is known about haem synthesis in erythroblasts or the 
factors that regulate the activities of the enzymes in the 
biosynthetic pathway. The principal problems that have hampered 
the study of erythroid haem synthesis have been the heterogeneity 
of cells in bone marrow samples in respect to lineage and maturity 
and the lack of suitably sensitive haem enzyme assays. The work 
detailed in this thesis has overcome these problems and has used 
"in vivo" human erythroblasts to examine the effect of normal and 
abnormal erythroid differentiation on ALA synthase activity.
(xv)
A highly sensitive radiochemical assay of ALA synthase activity, 
capable of detecting enzyme activity in 2 x 10  ^bone marrow cells, 
is described. This developed assay utilised reverse phase high 
performance liquid chromatography to isolate [1^C]-ALA pyrrole 
from radioactive substrate and metabolites. [i^C]-§ficcinate was 
preferred to 2-keto[^C]glutarate as radioactive substrate and the 
enzyme assay was optimised with respect to marrow sample 
preparation, ALA pyrrole production, [^^C]-succinate, CoA, GTP, 
succinate thiokinase, EDTA and succinylacetone concentration to 
obtain maximal ALA synthase activity. The mean enzyme activity in 
11 normal unfractionated bone marrow samples (893 +_ 199 pmol 
ALA/10^ erythroblasts/h) was approximately 50% greater than that 
recorded with the next most sensitive assay method.
Cytotoxic (IgM) monoclonal antibody TG-1 is specific for myeloid 
cells. It was used to obtain highly purified populations of 
marrow erythroblasts and to calculate the percentage contribution 
made by myeloid cells to ALA synthase activity in unfractionated 
bone marrow samples. In both normal and sideroblastic samples 
approximately 50% of the total enzyme activity was shown to be 
myeloid in origin. As previous studies using unfractionated' human 
bone marrow have assumed insignificant myeloid ALA synthase 
activity, their results and conclusions require to be reassessed.
Age matched populations of erythroblasts were obtained by percoll 
equilibrium density centrifugation of the marrow erythroblasts 
following TG-1 lysis of myeloid cells. ALA synthase activity was
(xvi)
examined during congenital dyserythropoietic (CDA), thalassaemic 
and sideroblastic erythropoiesis. The results suggest that ALA 
synthase activity does not limit human erythroblast haem synthesis 
and that reduced ALA synthase activity is not the cause of primary 
acquired sideroblastic anaemia (PASA). Rather it is suggested 
that the reduced enzyme activity, as was found in iron loaded 
erythroblasts and ring sideroblasts, resulted from iron-mediated 
enzyme toxicity. It is further postulated that reduced ALA 
synthase activity as found in two cases of CDA and one of 
thalassaemia resulted from high transferrin saturation with 
consequent erythroblast iron overload, whereas in PASA enzyme 
inactivation and ring sideroblast formation resulted from a 
primary abnormality of erythroblast iron metabolism.
(xvii)
ABBREVIATIONS
ALA 5-aminolaevulinic acid
ATP adenosine triphosphate
AUFS absorbance units full scale
BFU-E burst forming unit - erythroid
CFU colony forming unit
-E erythroid
-GEMM granulocyte erythroid macrophage monocyte
-GM granulocyte macrophage
-S spleen
CDA congenital dyserythropoietic anaemia
CoA coenzyme A
cpm counts per minute
DMAB p? N^dimethylaminobenzaldehyde
DNAase deoxyribonucleotidase
DOVA dioxovaleric acid
dpm disintegrations per minute
E^ early basophilic and pro erythroblasts
E2 intermediate polychromatic erythroblasts
E3 late orthochromatic erythroblasts
EDTA ethylene diamine tetracetic acid
(xviii)
FEL Friend erythroleukaemia cells
GTP guanosine triphosphate
HCR haem controlled repressor
HPLC high performance liquid chromatography
(RPHPLC) reverse phase
INH isoniazid (isonicotinic acid hydrazine)
MDS myelodysplastic syndromes
M:E myeloid: erythroid
MEM minimum essential medium
ODS octa decyl silane
PASA primary acquired sideroblastic anaemia
PLP pyridoxal-5-phosphate
STK succinate thiokinase (succinyl CoA synthetase)
TCA trichloroacetic acid
TIBC total iron binding capacity
CHAPTER 1
INTRODUCTION
1. INTRODUCTION
^  .The Greek word "fro^vpoo" "porphuros" meaning purple provides the
stem for "porphyry" a purple rock quarried by ancient Egyptians 
and "porphyre" "a serpent about the bignesse of a span or more 
which in outward aspect was the most beautiful and well coloured 
purple" (Topsell, 1658), It is more frequently used in the word 
"porphyrin" taken from "haematoporphyrin" used by Hoppe Seyler 
(1871) to describe the major constituent of an iron free 
preparation of blood.
The structure of porphyrins may be broken down to reveal a basic 
tetrapyrrole arrangement. Each pyrrole represents a closed ring 
containing 1 nitrogen and 4 carbon atoms. The pyrroles are linked 
by methine bridges in either a cyclical or linear form. The vital 
and ubiquitous role of the cyclical tetrapyrroles is attested to 
by their presence in haem (Fig.l), the iron chelate of 
protoporphyrin IX, chlorophyll, the magnesium chelate of 
protoporphyrin IX and in the bacterial corrin, vitamin Bj_2, the 
cobalt chelate of uroporphyrinogen III derivatives.
The porphyrin structure of haem and chlorophyll was first 
described by Hans Fischer (1881-1945). The Nobel medal for 
chemistry, which shows the figure of science unveiling the goddess
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Figure 1 : The cyclical tetrapyrrole structure of haem
Isis, was awarded to Fischer in 1930 for unveiling the secrets of 
Nature "in showing that despite her extravagant diversity she had 
been sufficiently economical to use the same building material 
when constructing two substances so greatly different in 
appearance and occurrence" (Soderbaum, 1930).
Porphyrins are readily visible and emit an intense red 
fluorescence when exposed to long wave ultraviolet light 
(400 rim). This property is utilised for biological purposes and 
has been used to detect coproporphyrin in crocodile excrement from 
the Eocene age, 25 million years BC (Fikentscher, 1933) and in the 
search for evidence of life in samples taken from lunar rocks.
Their production in both plants and animals requires 
5-aminolaevulinic acid (ALA) from which protoporphyrin IX is 
produced. At this point the biosynthetic pathways diverge, plants 
to chlorophyll, animals to haem. The pathways further differ in 
their production of ALA as the basic building unit. In man ALA is 
produced by the enzymatic coupling of succinyl CoA with glycine, 
whereas in plants it is produced in a three step process from 
L-glutamic acid through dioxovaleric acid (DOVA). Varticovski 
(1980) has shown that this latter pathway may not be restricted to 
plants, as labelled DOVA may be incorporated into ALA and haem in 
\ rats.^'However the balance of the paired reaction of DOVA 
transaminase and alanine-glyoxylate transaminase favours the 
reverse reaction with the formation of glycine (Moore and Disler,
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1985). If L-glutamic acid is a source of erythroid ALA in man 
(see Milgrom, 1985) it is likely to be a very minor one.
1.1 HAEM
Haem serves a critical metabolic function in animals as the 
prosthetic group of biologically important haem proteins which 
include haemoglobin, myoglobin, cytochromes P450 and P448, b type 
cytochromes, peroxidases, catalase and tryptophan pyrrolase. In 
addition, within developing erythroid cells haem may also be 
involved in the regulation of protein synthesis, iron uptake and 
differentiation (Chapter 5).
1.1.1 The formation of haem
The synthesis of haem occurs by an essentially unbranched pathway 
which consists of a series of irreversible reactions (Fig 2). The 
first (ALA synthase) and last three biosynthetic enzymes 
(coproporphyrinogen III oxidase, protoporphyrinogen III oxidase 
and ferrochelatase) are localised within the mitochondria with the 
intermediate enzymes in the cytosol. Two molecules of ALA, formed 
in the mitochondria, are condensed to form the colourless 
monopyrrole porphobilinogen (PBG). Thereafter PBG-deaminase and 
uroporphyrinogen III cosynthase act in concert to condense four 
molecules of PBG to hydroxymethylbilane from which the first 
porphyrin, uroporphyrinogen III is formed, with production of less 
than 1% of the symmetrical series I isomer. The side chains of 
uroporphyrinogen III are then modified by a series of
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Figure 2: The pathway of haem biosynthesis
decarboxylation reactions to give protoporphyrinogen IX which is 
readily oxidised to protoporphyrin IX before the insertion of Fe^+ 
and haem formation.
1.1.2 ALA synthase (EC 2.3.1.37)
AT.A synthase, loosely bound to the inner mitochondrial membrane, 
catalyses the condensation of glycine and succinyl CoA to form 
ALA. Glycine reacts with succinyl CoA to form the short lived
spontaneously decarboxylates to yield ALA (Gidari and Levere, 
1977). Pyridoxal 5 phosphate (PLP) is required as an essential 
cofactor (Shemin and Russell, 1953).
Pyridoxamine phosphate and PLP are the active coenzyme forms of 
pyridoxine (vitamin B6). As shown below the most common type of 
reaction requiring PLP is transamination, the transfer of the 
cr-amino group of one amino acid to the carbon of an ot-keto acid 
(Lehninger, 1972).
enzyme bound intermediate a—amino-$-ketoadipic acid which
COOH #COOH
# COOH ch2 co2 ch2
1 *  1
CH2 COOH •C = 0 •C = 0
CoA
0 = C-S-CoA hc-nh2 ch2
COOH NH2
The carbon atoms originating from the carboxyl atoms 
of succinyl CoA are marked.
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1.2 THE STRUCTURE OF ALA SYNTHASE
The molecular weight of isolated ALA synthase is dependent upon 
the nature of the animal species studied and the source of the 
tissue. The conditions under which the enzyme is purified are 
also important as buffers of low ionic strength may cause enzyme 
aggregation (Sassa and Kappas, 1981). The erythroid and liver iso 
enzymes have been shown to be structurally and immunologically 
different (Bishop et al, 1981; Watanabe et al, 1983). Although 
the enzyme is functionally active only in the presence of succinyl 
CoA, and hence only in the mitochondria, it is produced in the 
cytoplasmic polyribosomes, as a larger precursor, from which it is 
transported to the mitochondria in association with proteolytic 
processing (Yamauchi et al, 1980; Yamamoto et al, 1981). In rat 
liver cytosol the enzyme is thought to exist as a complex of one 
catalytically active and two inactive subunits of molecular weight 
51,000, 79,000 and 120,000 respectively (Oshashi and Kikuchi,
1979) with which the active mitochondrial enzyme is 
immunochemically identical and formed as a dimer of two active 
subunits (Nakakuki et al, 1980). In chicken liver and bone marrow 
the cytosolic enzymes have molecular weights of 73,000 and 55,000 
from which fragments of 8,000 and 2,000 respectively are cleaved 
during transport to the mitochondria (Watanabe et al, 1983).
1.3 THE ROLE OF ALA SYNTHASE IN THE REGULATION OF HEPATIC
HAEM BIOSYNTHESIS
The half life of ALA synthase is very short, 34 min in foetal rat 
liver (Woods, 1974) and 160 min in culture chick embryo liver 
cells (Sassa and Granick, 1970). This is considerably shorter 
than the approximate 5 day half life of general mitochondrial 
proteins (Druyan et al, 1969) and permits the regulation of liver 
ALA synthase by mechanisms which control the rate of enzyme 
synthesis.' In liver, ALA synthase is the rate limiting step in 
haem biosynthesis (Granick and Urata, 1963) and is subject to 
feedback control by "free" intracellular.haem at transcriptional 
(Whiting, 1976) and translational (Strand et al, 1972a) levels: 
haem has also been shown to inhibit the translocation of cytosolic 
enzyme to the liver mitochondria (Yamauchi et al, 1980; Yamamoto 
et al, 1981). This active "free" intracellular haem pool will 
inevitably be small and have a rapid turnover, a necessary 
requisite for a controlling substance (Moore and Disler, 1985).
Within human erythroid cells there is as yet no clear picture as 
to what role ALA synthase plays in haem biosynthesis and what 
factors regulate enzyme activity. The principal reasons for this 
have been the lack of suitably sensitive assays of haem synthetic 
enzyme activity and an inability to separate bone marrow erythroid 
cells from each other on the basis of differentiation status and 
from the contaminating myeloid cells present in the marrow cavity 
(Ibrahim et al, 1983; Beaumont et al, 1984).
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1.4 EXPERIMENTAL OBJECTIVES AND LAYOUT OF THESIS
The importance of ALA synthase activity in the regulation of 
hepatic haem biosynthesis and its role in the overproduction of 
porphyrins and/or their precursors in the different porphyrias has 
been defined (for review see Moore and Disler, 1985). Despite the 
fact that erythroblasts synthesise 85% of the total body haem 
produced each day (Berk et al, 1976) the importance of ALA 
synthase in the regulation of erythroid haem biosynthesis and its 
role in the development and pathogenesis of anaemias, in 
particular the sideroblastic anaemias, is uncertain.
It was the aim of the work discussed in this thesis to overcome 
the problems relating to the study of human bone marrow and 
erythroblast ALA synthase activity. The various chapters detail 
in stepwise fashion the progress made. The relevant literature 
and the particular problems anticipated at each step are presented 
in the introduction to each individual chapter.
The development of a sensitive radiochemical assay method for the 
measurement of ALA synthase activity in small numbers of human 
bone marrow cells is described in Chapter 2. The developed assay 
was used to measure ALA synthase activity in crude unfractionated 
samples of human bone marrow. The results are presented in 
Chapter 3 and the performance of the assay compared with published 
methods. Enzyme activity in unfractionated human bone marrow has 
been regarded, in all previous studies, as a measure of
7
erythroblast ALA synthase. The validity of this assumption is 
tested in Chapter 4 and the percentage contribution made by 
myeloid cells towards ALA synthase activity in unfractionated 
normal and sideroblastic bone marrow is reported. In Chapter 5 
marrow fractionation procedures are described which have permitted 
the direct measurement of ALA synthase activity within age matched 
normal and pathological erythroblasts. The results have been used 
to examine the role of ALA synthase in the regulation of 
erythroblast haem biosynthesis and the significance of reduced ALA 
synthase activity in the development of primary acquired 
sideroblastic anaemia (PASA).
1.5 ALA SYNTHASE ACTIVITY AND SIDEROBLASTIC ANAEMIA
Iron deficiency anaemia is the most common and the clearest 
clinical manifestation of haem deficiency. Erythrocyte 
protoporphyrin levels are raised but there is as yet no 
information on the effects that haem deficiency have on 
erythroblast ALA synthase activity.
The sideroblastic anaemias are a rare group of dysplastic marrow 
disorders, which with respect to the congenital and primary 
acquired forms, have been associated with reduced bone marrow ALA 
synthase activity. This reduced haem synthetic enzyme activity is 
thought to represent the primary defect of erythroblast 
metabolism, responsible for the development of mitochondrial iron
8
loading and ineffective erythropoiesis (Aoki et al, 1974; Aoki, 
1980; Ponka and Neuwrit, 1974; Bottomley, 1977, 1982). See 
Chapter 5.
Gruneberg (1941) applied the term "siderocyte" to the iron loaded 
erythrocytes of flexed-tailed mutant (f/f) foetal mice. 
Erythroblast iron granules were first described by Douglas and 
Dacie (1953). They concluded that normal erythroblasts could 
contain up to six small iron granules and that the number of 
marrow sideroblasts was related to the percentage transferrin 
saturation. The first description of acquired anaemia with 
hypochromic red cells and sideroblasts in the bone marrow 
(Bjorkman, 1956) was followed by the classic account by Dacie et 
al (1957) of refractory normoblastic anaemia with sideroblasts in 
the bone marrow. These seven cases undoubtedly established 
primary acquired sideroblastic anaemia (PASA) as a diagnostic 
entity. However Dacie's term "cuff" to describe the perinuclear 
siderotic granules, has not prevailed and has since been replaced 
by "ring", introduced by Bowman (1961). As used in the 
following text: "ring sideroblast" describes erythroblasts 
(+. dyserythropoietic features) with ^ 5 large siderotic granules 
extending ^ 1/3 of the nuclear circumference (see Plate 1), in 
which the iron granules are known to be present within 
mitochondria (Caroli et al, 1957); "pathological sideroblast" to 
describe non ring forms with > 7 large iron granules in the 
cytoplasm.
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Reduced ALA synthase activity in pyridoxine responsive congenital 
sideroblastic anaemia is thought to result from increased 
sensitivity of apo ALA synthase to an erythroblast protease 
specific for pyridoxal enzymes (Aoki, 1978; Aoki et al, 1979; 
Manabe et al, 1982). The therapeutic benefit of pyridoxine has 
been explained asJ a stabilising effect on the enzyme, through 
which normal sensitivity is restored (Manabe et al, 1982). In the 
preleukaemic form of sideroblastic anaemia, PASA, there is no 
therapeutic response to pyridoxine and reduced ALA synthase 
activity is thought to reflect reduced enzyme production.
1.6 ALA SYNTHASE ACTIVITY AND PORPHYRIA
Acute intermittent porphyria (AIP) is associated with increased 
ALA synthase activity in liver (Tschudy et al, 1965) and 
peripheral blood leucocytes (Brodie et al, 1977). This led to the 
initial hypothesis that AIP might represent the first genetic 
disease characterised by enzyme overactivity (Tschudy et al,
1965). It is now known that the human porphyrias comprise a group 
of inherited and acquired disorders characterised by reduced 
activity of specific haem enzymes as observed in liver cells, 
erythrocytes, leucocyte pellets, cultured fibroblasts, cultured 
amniotic cells and mitogen stimulated lymphocytes (for review, see 
Sassa and Kappas, 1980) and associated with enzyme overactivity at 
stages preceding the deficient enzyme. Interest in the porphyrias 
is considerable, however their relevance to the work described by
10
this Scotsman lies not with their causing transfer of the Crown 
from the Scottish House of Stewart to that of Hanover+ (McAlpine 
and Hunter, 1966; Mcalpine et al, 1968), but with a seemingly 
curious paradox; while primary porphyric aberrations in haem 
synthetic enzymes as evidenced in many tissues, do not disturb 
bone marrow function, reduced ALA synthase activity in PASA is 
considered sufficient cause of a refractory anaemia associated 
with erythroid hyperplasia and mitochondrial iron loading.
+ The Act of Settlement 1701 transferred the Crown from the 
Scottish House of Stewart to that of Hanover. The Act had been 
required to safeguard the Protestant succession, jeopardised by 
the failure of Queen Anne (1665-1714) to leave a Protestant heir 
a failure postulated to have been caused by the "Royal Malady" 
porphyria.
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CHAPTER 2
DEVELOPMENT OF AN ASSAY TO DETERMINE 
5-AMINOLAEVULINIC ACID SYNTHASE ACTIVITY 
IN HUMAN BONE MARROW
2. DEVELOPMENT OF AN' ASSAY TO DETERMINE
5-AMINOLAEVULINIC ACID SYNTHASE ACTIVITY 
IN HUMAN BONE MARROW
2.1 PRINCIPLE OF ENZYME ACTIVITY ASSAYS
The amount of enzyme activity in a given tissue is usually defined 
as the amount of product from substrate per unit time under 
certain specified conditions (Mahler and Cordes, 1969). Where 
possible enzymes are assayed in test conditions in which the pH is 
optimum and the substrate concentration is above the saturating 
level, so that the initial reaction rate is zero-order for 
substrate. When catalysed reactions are zero-order for substrate 
and cofactors the rate of the reaction is proportional to enzyme 
concentration alone (Lehninger, 1972).
2.2 COLORIMETRIC DETERMINATION OF ALA
The original method developed to measure ALA was a colorimetric 
assay first described by Mauzerall and Granick (1956) and 
subsequently used as the basis of colorimetric assays of tissue 
ALA synthase activity (see Burnham 1970). In the original method 
ALA was converted to a pyrrole by adding either acetylacetone or 
ethyl^cetoacetate. The resulting ALA pyrrole was reacted with 
modified Ehrlich reagent and quantified by spectrophotometry at 
555 nm. The chemistry of pyrrole reactions with Ehrlich reagent 
is complex (Falk, 1964) but in relation to the reaction with ALA
pyrrole (P) a coloured salt (E) is formed by the reaction of the 
free a-hydrogen on the pyrrole with the dimethylaminobenzaldehyde 
(DMAB) in the Ehrlich reagent (Lien and Beattie, 1982).
P DMAB ' E
The colour is not stable and should be read at 15 min as the 
coloured salt (E) can react with another molecule of pyrrole (P) 
to form a colourless compound.
The major drawbacks of the colorimetric assay are the formation of 
aminoacetone pyrrole which also reacts with Ehrlich reagent and 
low sensitivity. Aminoacetone is formed by the condensation of
glycine with acetyl CoA, catalysed by aminoacetone synthase, or by
r{ the oxidation of thjeonine (Lien and Beattie, 1982). The limit of 
detection with colorimetric assays is about 3 nmol ALA/ml (Falk 
1964). As such they are not suitable for use with tissues 
containing low levels of ALA synthase, or with tissues such as 
human bone marrow'available only in small quantities.
2.3 FLUORIMETRIC ASSAY OF ALA SYNTHASE
A fluorimetric assay sensitive to ALA synthase activity in the 
pmol/ml range has been described (Bishop et al, 1982) but has not
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been used successfully to detect enzyme activity in bone marrow 
lysates (Bottomley and Moore, 1982).
2.4 RADIOCHEMICAL ASSAYS OF ALA SYNTHASE
ALA synthase activity in liver (Irving and Elliot, 1969), in human 
bone marrow (Bottomley et al, 1973), in "in vitro" cultured cell 
lines (Ebert and Ikawa, 1974), in "in vitro" bone marrow cultures 
(Ibrahim et al, 1982) and in peripheral blood leucocytes (Brodie 
et al, 1977) is most often detected by radiochemical assay, 
sensitive to the detection of 10-100 pmol ALA/ml (Irving and 
Elliott, 1969).
With radiochemical assays in general there are problems with the 
choice of radioactive substrate and the specificity of radioactive 
ALA isolation. In addition a problem peculiar to the use of 
radiochemical assays with erythroid tissues is the loss of 
radioactive ALA that occurs during the period of sample and 
substrate incubation. This is known as ALA UTILISATION (Strand et 
al, 1972; Bottomley et al, 1973).
2.4.1 Choice of radioactive substrate
Succinyl CoA and glycine are the direct substrates of ALA synthase 
and both [^C] -succinyl CoA (Aoki et al, 1974) and [^C]-glycine 
(Freshney and Paul, 1970) have been used in radiochemical assays 
of ALA synthase activity. There are however problems with both. 
The Km of ALA synthase for glycine is high 4.2 mmol/1 (Freshney
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%and Paul, 1970), 2.5 - 7.5 mmol/1 (Nakakuki et al, 1980). As this 
is approximately 160 times the Km for succinyl CoA (Aoki et al, 
1974) it has been thought that [^^C]-glycine may not be a 
practical choice of substrate (Bishop and Wood, 1977).
The Km for succinyl CoA is extremely low, 11 umol/1 (Nakakuki et 
al, 1980). However, at -20°C the stability of [l4C]-succinyl CoA 
is only in the order of weeks and during incubation at 37°C for 30 
min some 50% may be non enzymatically hydrolysed (Aoki et al, 
1974). As [14C] -succinyl CoA is not commercially available its 
use over a prolonged period of time would require its repeated 
preparation from [^4C]-succinic anhydride, an extremely expensive 
radiochemical.
These problems have led to the more frequent use of either 2-keto 
[^4C]glutarate or [ 14c]  -succinate. Neither 2-keto 
[l4C]-ketoglutarate, initially used by Ebert et al (1970) or 
[ 14c]  -succinate (Irving and Elliott, 1969) are[direct substrates 
of ALA synthase. Both are intermediates of the citric acid cycle 
(Fig 3) and require to be metabolised to [^4C]-succinyl CoA.
Conversion of 2-ketoglutarate to succinyl CoA:
2-ketoglutarate dehydrogenase (EC 1.2.4.2.) is an enzyme complex 
that catalyses the irreversible oxidative phosphorylation of 
2-ketoglutarate to succinyl CoA. Thiamine pyrophosphate, lipoic 
acid, CoA, NAD and FAD are required as enzyme bound cofactors 
(Lehninger, 1972).
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Note: The citric acid cycle is the central pathway for the
degradation of two carbon acetyl residues derived from 
carbohydrate, fatty acid or amino acid metabolism.
The cycle yields CO  ^ and H+ ions. The latter are led 
via the electron transport system to molecular oxygen.
Figure 3 : The citric acid cycle in relation 
to cell respiration
2-ketoglutarate
dehydrogenase.
CoA SH + 2-ketoglutarate succinyl CoA + C02 + H+
NAD NADH
The Km of the enzyme for CoA is lQ-^M and for 2-ketoglutarate 1.3
x 10"* M^ (Massey, 1960). Although both are low and 2-keto[^^C] 
glutarate is commercially available, the enzyme 2-ketoglutarate 
dehydrogenase is difficult to obtain. In the absence of exogenous 
2-ketoglutarate dehydrogenase the assay of ALA synthase using
in the activity of endogenous 2-ketoglutarate dehydrogenase. This 
would then enable reduced 2-ketoglutarate dehydrogenase activity 
to effect an apparent reduction in ALA synthase activity.
Conversion of succinate to succinyl CoA:
Succinate thiokinase (STK) (EC 6.2.1.5.) catalyses the reversible 
conversion of succinate to succinyl CoA in the presence of Mg++ 
and triphosphate.
2-keto[l^C]glutarate as substrate would be subject to fluctuations
COOH COOH
CH2 ATP ADP c h2
COOH 0 C S CoA
Succinate Succinyl CoA
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The apparent Km of ALA synthase for succinate and CoA in an assay 
system containing exogenous STK and partially purified ALA 
synthase was 3.3 x 10“^M (Bishop et al, 1982). [^^C]-succinate is ' 
used more frequently than 2-keto[1^C]glutarate for the measurement 
of ALA synthase activity. Radioactive succinate is cheap and 
stable. In addition GTP dependent porcine STK is readily 
available and so allows with ease the addition of an exogenous 
succinyl CoA generating system.
With each particular tissue under study however the need for 
provision of such a system should be determined. The assay of ALA 
synthase in human reticulocytes, (Strand et al, 1972) in crude 
liver homogenates from mice and humans but not from rats requires 
an exogenous succinyl CoA generating system for maximal activity 
(Bonkowsky and Pomeroy, 1978).
Furthermore with a view to maximising the conversion of 
[ 14c]  -succinate to [14C] -succinyl CoA during incubation, citric 
acid cycle inhibitors and potassium fluoride may be added to the 
reaction mixture (Ebert et al, 1970; Strand et al, 1972).
Citric acid cycle inhibitors and potassium fluoride:
'~9 Sodium malonate (10mM), sodium Dl^“ malate (5mM) and antimycin A 
(2.5 ug/ml) respectively can be used to inhibit succinate 
dehydrogenase, trap [l^C]-malate and block the electron transport 
chain. These would effect inhibition of the citric acid cycle and 
f might maximise [-^C]-succinate availability for STK (Brooker et
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al, 1982). It has been shown that mitochondrial synthesis of 
succinyl CoA from 2—ketoglutarate may be prevented by inhibition 
of 2—ketoglutarate dehydrogenase with arsenite (Granick and Urata, 
1963). Arsenite has been used with [^C]-succinate based assays 
of ALA synthase to inhibit synthesis of cold succinyl CoA from 
endogenous 2—ketoglutarate and so prevent dilution of the 
[14C] -succinyl CoA with cold succinyl CoA (Ebert et al, 1970). In 
practice however arsenite is infrequently used as it also inhibits 
ALA synthase activity (Irving and Elliott, 1969; Ebert et al,
1970) and presents a hazard fr'om its use in the chemical 
laboratory (Muir, 1977).
The addition of potassium fluoride (100 mM) to the reaction 
mixture has been found to produce a twofold increase in measurable 
ALA synthase activity in liver homogenates (Yoda et al, 1975). 
Fluoride is thought to inhibit ATPases and GTPases which might 
limit the effect of triphosphate dependent STK and so restrict 
succinyl CoA generation.
In principle inhibitors are used to maximise [^C]-succinate 
utilisation by STK and promote this route as the only source ^ of 
succinyl CoA in the assay system. It is however, thought that the 
use of an exogenous succinyl CoA generating system may make the 
addition of these inhibitors unnecessary (Bishop et al, 1982).
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In view of the instability and the expense involved in the 
preparation of [^C]-succinyl CoA and the high Km value of ALA 
synthase for [^C]-glycine, neither radiochemical was used. Both 
r14c]  -succinate and 2-keto[^C]glutarate were chosen for this 
study to examine their suitability for measuring bone marrow ALA 
synthase activity.
2.5 SPECIFIC ISOLATION OF ALA
The greatest source of error in the radiochemical measurement of 
ALA synthase activity lies in the inability of methods to 
specifically isolate [^^C]-ALA from other radioactive substances 
in the enzyme reaction mixture (Patton and Beattie, 1973). The 
first radiochemical assay developed combined single column ion 
exchange chromatography with solvent extraction of ALA pyrrole by 
ethy^acetate as a means of isolating radioactive ALA (Irving and 
Elliott, 1969). The method of separation was modified and made 
more simple by Ebert et al (1970) and so a rapid and sensitive 
radiochemical assay became available for use with tissues such as 
human bone marrow only available in small quantities. The 
introduction of a sequential multicolumn ion exchange procedure 
improved specificity (Strand et al, 1972) but replaced simplicity 
with a technique that was tedious and liable to produce 
significant variability in ALA recoveries from duplicate samples 
(Schacter et al, 1976). With partially purified preparations of 
enzyme the number of ion exchange fractionations may be reduced 
(Aoki et al, 1974). However, incomplete separation of [^^C]-ALA 
from other radioactive compounds has remained a problem with
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assays using mitochondria or crude liver homogenates (Bishop and 
Wood, 1977; Managa et al, 1978; Wolfson et al, 1980). A modified 
Beckman aminoacid analyser has been used to improve separation 
(Bishop and Wood, 1977) and "clean up" procedures have been 
developed to rid commercial radioactive succinate of impurities 
that might contaminate isolated [^^C]-ALA (Condie et al, 1976; 
Bishop and Wood, 1977; Brooker et al, 1982). Sodium dodecyl 
sulphate used in place of trichloroacetic acid to stop the 
reaction eliminated contaminants that separated with ALA during 
ion exchange chromatography but reduced enzyme activity and 
produced variable recovery of the internal standard (Scotto et al, 
1983). With assays using [l^C]-glycine (Freshney and Paul, 1971) 
high voltage paper electrophoresis can be used to separate 
[1^C]-ALA from [ -glycine (Rutherford et al, 1979). The 
application of reverse phase (RP) HPLC to the assay of ALA 
synthase was first described by Tikerpae et al (1981). As RPHPLC 
was seen to offer a simple and rapid means of isolating [^^C]-ALA 
and also allow for the incorporation of internal standard in each 
sample it was decided to investigate RPHPLC as a means of 
achieving single column separation of [^^C]-ALA without need for 
ether extraction or freeze drying (Tikerpae et al, 1981).
2.3.1 Principles of HPLC
Liquid chromatography is a widely used chemical separation method 
based on interactions between solutes, liquid mobile phase and 
solid stationary phase. Separation takes place in a column 
containing the chromatographic material (ie the stationary phase)
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in the form of small particles. The liquid solvent (ie the mobile 
phase) is pumped through the particle bed. This arrangement 
allows sample components dissolved in the mobile phase to interact 
in a reversible manner with the stationary phase. Separation is 
achieved on the basis of the relative affinities of the different 
sample components for the stationary and mobile phases.
Components with a strong affinity for the stationary phase will 
elute later than those with a greater affinity for the mobile 
phase.
HPLC differs from classical chromatography in that the system 
operates under high pressure and has been optimised to increase 
speed, resolution and sensitivity. The set up for HPLC requires 
that a delivery system is connected to the chromatography column 
in order to feed it with fresh mobile phase. The system consists 
of a solvent reservoir and a pump capable of pumping under high 
pressure (6000 psi) and producing an even flow of mobile phase 
through the column without pulsation. The sample to be 
chromatographed is applied as a precise volume via the sample 
injector which is positioned just prior to the column. After 
passing through the column the separated sample components are 
monitored by a detector and collected by a fraction collector (LKB 
1982).
The detector
ALA pyrrole formed by the condensation of ALA with 
ethylacetoacetate may be detected by UV spectrophotometry at
252 mn (Tikerpae et al, 1981). UV absorption is a molecular 
property and thus each compound will have its own specific 
absorbance. UV detectors are sensitive to the nanogram level of 
detection.
2.5.2 Principles of reverse phase HPLC
RPHPLC utilises differences in the solubility properties of 
compounds in a sample to achieve separation. Substances that show 
little solubility in water but which are readily soluble in 
organic solvents are called hydrophobic; organic solvents 
themselves are hydrophobic. On the other hand hydrophilic 
substances are readily soluble in water but not in organic 
solvents. In RPHPLC the mobile phase is always more hydrophilic 
than the stationary phase and so hydrophilic compounds will always 
move faster than hydrophobic ones.
The ability of the stationary phase to effect separation may be 
influenced in three different ways.
1. Alter the hydrophobicity of the stationary phase.
2. Alter the hydrophilic properties of the mobile phase. This 
may be done by altering the amount of organic solvent in the 
mobile phase.
3. Alter the hydrophobicity of the compounds in the sample to be 
separated. This may be done by:
1. altering the pH, or
2. adding an ion-pairing agent to the mobile phase.
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Types of stationary phase:
In RPHPLC silica particles covered with chemically bonded 
hydrocarbon chains represent the hydrophobic stationary phase.
The retention of hydrophobic compounds is related to the length of 
the hydrocarbon sidechains. A bonded sidechain with 18 carbon 
atoms (a C18 layer, ODS) is more hydrophobic than a C8 layer which 
in turn is more so than a C2 layer. RPHPLC columns are available 
with any one of these three packings. The C18 packing provides 
maximum resolving power for hydrophobic compounds.
Hydrophobicity of the sample:
Ionic compounds show low hydrophobicity because of the hydrophilic 
character of charged groups. These charges may be neutralised by 
the use of buffers or by the addition of ion-pairing agents which 
form electrostatic complexes with charged components in the 
sample. The ion-pairing agent is bulky and the ion-ion bond 
formed will be shielded by the rest of the molecule so rendering 
the complex considerably more hydrophobic than the separate parts.
2.6 INCUBATION MEDIUM FOR ALA SYNTHASE ACTIVITY
The composition of the ideal incubation medium used in an assay of 
enzyme activity is such as to allow maximum product synthesis.
The pH profile for ALA synthase activity has shown a broad optinta'* 
around 7.4 (Strand et al, 1972), 7.5 (Bishop et al, 1982) and 7.6 
for highly purified enzyme (Nakakuki et al, 1980). Enzyme
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activity is almost universally measured between pH 7.2 - 7.6 and 
pH of 7.4 was chosen for use in this work without further 
experimentation. The acetate buffering system already 
successfully used for ALA pyrrole isolation with RPHPLC was also 
adopted (Tikerpae et al, 1981).
In principle the reaction mixture should contain all reagents
required for the conversion of [^C]-substrate to [^C]-ALA.
Ideally these reagents should also be present at saturating 
levels. The [^^C]-ALA formed during the reaction should be 
preserved and its further metabolism by ALA dehydratase 
inhibited. The need for individual constituents in the reaction 
mixture will be discussed.
2.6.1 Sucrose
Sucrose is commonly present in the incubation medium (Rutherford 
et al, 1979; Wolfson et al, 1980; Tikerpae et al, 1981) as it is 
thought that sucrose may provide osmotic stability for ALA 
synthase during tissue homogenisation.
2.6.2 Glycine
Glycine is the immediate substrate for ALA synthase. It has been 
shown that the enzyme in bone marrow is saturated with 25 mM 
glycine (Bottomley et al, 1973). A concentration of 50 mM 
glycine, as was used in previous studies (Irving and Elliott, 
1969; Tikerpae et al, 1981; Ibrahim fet al, 1982) was chosen for 
this work without further experimentation.
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2.6,3 Pyridoxal phosphate
Although PLP is an essential cofactor for ALA synthase, exogenous 
PLP may not be necessary for the detection of maximum enzyme 
activity in normal bone marrow (Bottomley et al, 1973). In 
situations in which it has been required for maximum enzyme 
activity 0.1 mM PLP has been shown to be saturating (Irving and 
Elliott, 1969; Bishop et al, 1982). For this study 0.4 mM PLP was 
used.
^ 2.6.4 2-ketof -^ C^l glutarate
/ 2-keto[^C]glutarate has been used for the detection of ALA
£-.
synthase activity in liver (Ebert et al, 1970) and in bone marrow 
(Bottomley et al, 1973; Konopka and Hoffbrand, 1979; Tikerpae et 
al, 1981). The saturating concentration of 2-ketoglutarate for 
the detection of ALA synthase activity in both tissues has been 
shown to be 0.17 mM and was used at this concentration in those 
samples to which 2-keto[l^C]glutarate was added as substrate.
2.6.5. Mg++
STK requires Mg++ as an essential cofactor (Ramaley et al, 1967). 
With the use of [^C]-succinate as substrate MgCl2 was present in 
the incubation medium at 20 mM while a concentration of 5 mM MgCl2 
was used with 2-keto[^^C]glutarate.
The concentration of the other reagents in the incubation medium 
| was individually optimised for maximum ALA synthase activity.
Their inclusion in the medium will be discussed here, but the
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experimental work carried out to determine their optimum 
concentration will be reported in Experimental and Results.
2.6.6 EDTA
EDTA was added to inhibit ALA dehydratase and so prevent the 
condensation of ALA formed during incubation to the monopyrrole, 
porphobilinogen. EDTA inhibits enzyme activity by chelating Zn++ 
(Bevan et al, 1980). Failure to inhibit ALA dehydratase leads to 
loss of ALA via ALA utilisation in assays of both liver and bone 
marrow ALA synthase. ALA utilisation in liver is abolished with 
1 mM EDTA (Ebert et al, 1970; Strand et al, 1972) but persists 
despite EDTA with the assay of erythroid ALA synthase (Strand et 
al, 1972; Bottomley et al, 1973).
There are other known potent inhibitors of ALA dehydratase such as 
sodium laevulinate, Pb++ and succinylacetone. Only sodium 
laevulinate has been used in the assay of ALA synthase activity 
and only then in intact cultured liver cells (Sinclair and 
Granick, 1977). Succinylacetone is a profound and specific 
inhibitor of hepatic and erythroid ALA dehydratase (Tschudy et al, 
1981; Sassa and Kappas, 1983). The effect of EDTA and 
succinylacetone on ALA utilisation and ALA synthase activity is 
reported in Experimental and Results.
2.6.7 CoA
CoA may be added to the incubation medium for assays that use 
either [^C] -succinate or 2-keto[^C]glutarate as it is required
by both for the formation of [l^C]-succinyl CoA. The amount of 
exogenous CoA required for maximum ALA synthase activity is 
dependent upon the nature of the tissue under study. With crude 
liver homogenate exogenous CoA is not required for maximal ALA 
synthase activity (Ebert et al, 1970). For those experiments in 
which 2-keto[l^C]glutaric acid was used as substrate, CoA was 
added to a final saturating concentration of 0.25 mM (Tikerpae et 
al, 1981).
\ I ^
2 .6.8 rl^Cl-succinate
The use of [^^C] -succinate as substrate requires either that 
adequate amounts of [^^C]-succinyl CoA are generated by the tissue 
itself or that an exogenous succinyl CoA generating system be 
provided. Commercial STK is GTP dependent. The optimum combined 
concentrations of [^^C]-succinate, CoA, GTP and STK for maximal 
ft/Tt- ALA synthase activity i^s reported in Experimental and Results.
2.7 TISSUE PREPARATION
2.7.1 Mitochondria or crude tissue homogenate
ALA synthase activity may be measured in mitochondrial fractions, 
in partially purified preparations of the enzyme or in crude 
tissue homogenate. Although it is desirable to detect functional 
ie mitochondrial ALA synthase, the loss of mitochondria during 
preparation has led to the suggestion that only crude tissue 
homogenate should be used when small amounts of tissue are
27
available (De Matteis and Hollands, 1982). In view of the small 
size of marrow samples crude tissue homogenate was used for all 
experiments.
2.7.2 Tissue homogenisation
Ultrasonic disintegration is used by most workers as a means of 
tissue preparation. It has been claimed that membrane 
solubilisation with deoxycholate in addition to sonication can 
increase detectable enzyme activity (Aoki et al, 1974). Both 
methods of preparation were tested and the results are reported.
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EXPERIMENTAL AND RESULTS
The aim of this work was to develop a simple single column RPHPLC 
method for specifically isolating ALA pyrrole, without solvent 
extraction, for use in the assay of ALA synthase activity. With 
respect to the assay itself it was aimed to identify either 
2-keto[l^C]glutarate or I 14c]  -succinate as the more suitable 
radiochemical and determine the optimum conditions under which 
enzyme activity might be assayed.
It was at the outset decided that the reaction would take place in 
a final volume of 0.5 ml in plastic eppindorfs at 37°C in a 
shaking water bath set to 60 rpm.
2.8 CHROMATOGRAPHIC PROPERTIES OF ALA PYRROLE
ALA pyrrole was prepared by the method of Mauzerall and Granick 
(1956) and was identified as 2-methyl-3-carbethoxy-4-(3-propionic 
acid) pyrrole by nmr spectroscopy. The chromatographic properties 
of the pyrrole dissolved in 50% (v/v) aqueous methanol were 
examined using a C18 RPHPLC column. The percentage concentration 
of aqueous methanol in the mobile phase was altered so as to 
determine the most useful concentration for routine use. Eluted 
pyrrole was detected by a UV spectrophotometer set to 252 nm and
a  ■
l.OiAUFS, collected m  30 sec fractions on the fraction collector, 
and was identified by its reaction with modified Ehrlich reagent.
m
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With 35% (v/v) aqueous methanol and 0.005 M heptane sulphonic acid 
(ion-pairing agent) as mobile phase, flow rate 1.5 ml/min, ALA 
pyrrole^eluted over a 90 sec period between 8 and 9 min as a 
single sharp peak (Fig 4). The peak height was directly related 
to the volume of pyrrole solution injected.
Both 2-keto[^Cj-glutarate and [-^C]-succinate eluted at the 
solvent front. Injection of 25,000 cpm of either [^^C]-succinate 
or 2-keto[^C]-glutarate with the prepared pyrrole showed that the 
cpm eluted completely within 2 minutes, with no radioactive 
contamination of the cold ALA pyrrole peak. Injection of 250,000 
cpm of either radiochemical, still considerably less than the cpm 
required for an individual assay, produced significant radioactive 
contamination (300-400 cpm) in the cold ALA pyrrole peak 
(background 15-20 cpm). This indicated that RPHPLC would not by 
itself achieve sufficient separation of ALA pyrrole from the large 
number of cpm in the radiochemical substrate required to detect 
ALA synthase activity.
With aqueous methanol 10% (v/v) as mobile phase for RPHPLC, ALA 
pyrrole did not elute within 30 min. This prolonged retention of 
ALA pyrrole on a C18 column at low methanol concentration in the 
mobile phase indicated that disposable C18 cartridges might 
achieve partial ALA pyrrole isolation prior to complete and 
specific isolation by RPHPLC. There are various C18 cartridges 
available, however the product of Waters Associates (Sep-pak 
cartridge) was chosen for use.
30
Time (mins)
Note: Aqueous methanol (35% v/v) containing 5 mM heptane
sulphonic acid was used as mobile phase, flow rate
1.5 ml/min. Spectrophotometric monitoring (— — -) 
at 252 nm detects ALA pyrrole elution at 9 min.
Radioactivity ( ) eluting at the solvent front
r e p r e s e n t s  P ^ C j - s u b s t r a t e  c l e a r  o f  [ ^ C ] - A L A  
p y r r o l e .  AUFS = a b s o r b a n c e  u n i t s  f u l l  s c a l e .
Figure 4: The isolation of ALA pyrrole using RPHPLC 
on an ultrasphere C18 OPS column (4.6 x 150 mm)
2.8.1 Trial of Sep-pak cartridge
ALA added to the incubation medium of Tikerpae et al (1981) was
' ^converted to ALA pyrrole by reaction with ethylacetoacetate.
0.05 ml of ALA solution (5 mM) was added to 0.45 ml of incubation 
medium. Trichloroacetic acid (TCA) (10%) 0.25 ml was added and 
the pH brought to 5.3 by the addition of 0.5 ml sodium acetate 
(1 M). Ethylacetoacetate^O.05 mlywas added and the mixture heated' 
to 100°C for 20 min in a loosely capped (capped with a marble) 
glass boiling tube. The tube was cooled rapidly in ice and water 
to 5 ml was added.
A C18 Sep-pak cartridge was activated by the successive injection 
of acetonitrile (l0 ml4 water [5 ml^ methanol 5 ml and water 10 ml. 
The ALA pyrrole solution was then injected through the cartridge 
at the rate of 5 ml/min (Fig 5). The ALA pyrrole solution and the 
Sep-pak eluant were reacted with modified Ehrlich reagent. ALA 
pyrrole was completely retained by the Sep-pak. Elution and 100% 
recovery of the pyrrole was obtained by injecting 3.0 ml of 
methanol through the cartridge. Each cartridge could be used four, 
times without deterioration and ALA pyrrole was shown to remain 
stable during the evaporation of the methanol under N£ at 35°C.
5 x 10^ cpm of either [-^C]-succinate or 2-keto[-^C]-glutarate 
were added to the ALA pyrrole solution. Less than 20,000 cpm were 
retained on the Sep-pak. This indicated the potential use of the 
Sep-pak cartridge as a means of partially isolating ALA pyrrole 
prior to RPHPLC.
Figure 5: The use of Sep-pak cartridge for 
partial isolation of [ l4Cj-AlA 
pyrrole from [14C]-substrate
Drying the Sep-pak:
For use within an assay system a technique was required which 
would dry the Sep-pak completely before the elution of ALA pyrrole 
in methanol. Failure to achieve complete drying of the Sep-pak 
was shown to prolong the stage of methanol evaporation.
It was shown that ALA pyrrole bound to the C18 Sep-pak was stable 
during drying of the Sep-pak under nitrogen blown through the 
cartridge or under air drawn through the cartridge by attachment 
to a benchside vacuum pump. Both methods produced a dry Sep-pak 
within 5 min and for convenience the vacuum method was adopted for 
regular use.
2.9 CONVERSION OF ALA TO ALA PYRROLE
ALA pyrroles may be produced from acetylacetone, succinylacetone, 
methyl^kcetoacetate or ethyljkcetoacetate. Tikerpae et al (1981) 
reported that the pyrrole prepared from ethylacetoacetate had the 
most suitable characteristics for rapid successive applications to 
the RPHPLC column. The RPHPLC properties of the ALA pyrroles
I prepared from ethyl/acetoacetate and acetylacetone were examined
/
under identical conditions.
! Either ethyllacetoacetate (0.05 ml) or acetylacetone (0.05 ml) was 
added to incubation medium (0.5 ml) (Tikerpae et al, 1981), 
containing 5 mM ALA (0.05 ml), 10% TCA (0.25 ml) and 1 M sodium 
acetate (0.5 ml). ALA pyrrole was prepared for RPHPLC as 
described (Section 2.8.1). Methanol from the sep-pak was 
evaporated and ALA pyrrole was resuspended in 0.1 ml methanol (50%
(v/v) from which 0.05 ml was taken for HPLC.
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There was no loss of pyrrole at the Sep-pak stage and both 
pyrroles eluted at approximately the same time from the column. 
However, acetylacetone pyrrole peak height was well off the scale 
set to record eluted ethylacetoacetate pyrrole (252 nm,
1.0 AUFS). In view of this effect it was decided to continue 
further work with ethylacetoacetate pyrrole.
2.9.1 Formation of ethylacetoacetate pyrrole
The effect of ethylacetoacetate on ALA pyrrole production was
examined.
5 mM ALA solution (0.05 ml) was added to glass boiling tubes 
containing incubation medium (0.5 ml) (Tikerpae et al, 1981),
10% TCA (0.25 ml), 1M sodium acetate (0.5 ml) at a final pH 5.3.
f
Both the effect of ethylacetoacetate and time of heating to 100°C 
on ALA pyrrole production were assessed. Each tube was immersed 
in boiling water, rapidly cooled in ice then diluted with water 
(5.0 ml). Thereafter each sample was diluted a further 1 in 4 
with water and reacted with equal volumes of modified Ehrlich 
reagent. The OD was read at 555 nm after standing for 15 min.
The amount of pyrrole formed after boiling for 10 min with 0.05 ml 
ethylkcetoacetone was 82% of that formed at 20 min. With
0.1 ml, pyrrole formation at 10 min was the same as that at 
20 min. The effect of altering the volume of ethylacetoacetate 
with boiling for 20 min was examined (Fig 6).
33
Ethylacetoacetate(pl)
Note: ALA pyrrole was formed as described in text. Pyrrole
production (20 min at 100°C) was measured by reaction 
with modified Ehrlich reagent. Each point represents 
the mean of two observations.
Figure 6 : The effect of ethylacetoacetate on 
ALA pyrrole production
Maximum pyrrole formation occurred with the addition of ^ 0.05 ml 
ethylacetoacetate which was adopted with a 20 min boiling period 
for routine use.
The effect of pH on ALA pyrrole formation was checked by altering 
the concentration of sodium acetate from 1.0 M to 2.0 M. It was 
found to be independent of pH over the range 5.3 to 6.5.
The extinction coefficient for ethylacetoacetate pyrrole is
7.2 x 104 molar (Mauzerall and Granick, 1956). Use of the formula
00Concentration (M) = ___________________________
Extinction Coefficient (M)
confirmed that under the conditions described ALA conversion to 
ALA pyrrole was 100%.
2.10 THE FINAL STEPS : FROM REACTION TERMINATION TO RPHPLC
These experiments established a method for reaction termination, 
ALA conversion to ALA pyrrole and pyrrole isolation by RPHPLC.
The method may be summarised as follows:
1. Terminate the ALA synthase reaction (final volume 0.5 ml) by 
the addition of 10% TCA (0.25 ml).
2. Add internal standard (0.05 ml 4 mM cold ALA) (section 2.11) 
and adjust the pH to 5.3 by the addition of 1 M sodium 
acetate (0.5 ml).
3. Spin down precipitated protein at 12,000 g' for 2 min in an 
eppindorf centrifuge and transfer the supernatant to a 10 ml 
capacity glass boiling tube.
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4. Add ethylacetoacetate (0.05 ml), loosely cap the boiling 
tube and heat to 100°C for 20 min.
5. Cool in ice, add water to 5 ml and inject the pyrrole 
solution through an activated C18 Sep-pak cartridge.
6 . Dry the Sep-pak by attachment to a benchside vacuum and
elute the pyrrole in methanol (3 ml).
7. Evaporate to dryness under N2 in a heating block at 35°C and
resuspend the pyrrole in 50% (v/v) aqueous methanol
(0.1 ml). Thereafter 0.05 ml may be taken for RPHPLC. 
Collect the column eluate in 30s fractions (0.75 ml), add
scintillant (8.0 ml) and count B emissions on a liquid
scintillation counter.
2.11 ALA RECOVERY
The use of RPHPLC permits the addition of large amounts of cold 
ALA (internal standard) at the end of incubation to each 
individual sample to assess ALA recovery. The ALA pyrrole peak 
height recorded with 0.05 ml 4 mM ALA (200 nmol), was 
approximately 80% of the maximum recorder deflection 
(spectrophotometer set to 252 nm and 1.0 AUFS). As ALA synthase 
activity in human bone marrow is in the pmol per hr range the 
[1^C]-ALA synthesised during incubation (pmol) would not 
contribute significantly to the recorded pyrrole peak height, 
which would reflect the conversion of cold ALA to ALA pyrrole.
200 nmol cold ALA was chosen as internal standard for routine use.
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The percentage recovery of internal standard was calculated by
, . jv; -C-- . .
adding [1^C]-ALA (0.025 uCi, 0.6 nmol) to eppindorfs containing
incubation medium without either bone marrow cells or radioactive
y*
substrate. These eppindorfs were treated in an identical fashion 
to those containing test marrow and the ALA pyrrole from these 
recovery samples was taken for RPHPLC. From the recorded cpm in 
the 0.025 uCi [-^C] ALA, recovery was calculated as the percentage
cpm recovered in the ALA pyrrole peak. The graph relating
percentage recovery to pyrrole peak height was linear and the peak 
height corresponding to 100% recovery was read off.
2.12 ALA UTILISATION
Loss of [-^C]-ALA resulting from its metabolism during the assay 
of ALA synthase is called ALA utilisation. The effect of cell 
number on ALA utilisation was assessed.
Homogenised bone marrow cells 2-40 x 10^ per 0.5 ml were prepared 
in incubation medium containing EDTA 10 mM (Tikerpae et al,
1981). Each concentration of bone marrow cells was prepared in 
quadruple. [^^C]-ALA 0.0025 uCi (65 pmol) was added to one pair
and 0.005 uCi (130 pmol) to the other. From these pairs one
r? (
hppmdorf was incubated for zero time and the other for 60 min at 
37°C. The percentage ALA utilisation for each sample was 
calculated from the cpm in ALA pyrrole at zero time and 60 min, 
corrected to 100% recovery of internal standard.
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Note: ALA utilisation was assessed as described in text
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Figure 7: The effect of bone marrow homogenate cell
number on ALA utilisation
The results show (Fig 7) that ALA utilisation was linear with cell 
number and similar with both 65 and 130 pmol of [1^C]-ALA.
A linear loss of [^^C]-ALA during incubation was also found by 
Ebert et al (1970) using increasing concentrations of liver 
homogenate in medium without EDTA. EDTA has been shown to inhibit 
ALA utilisation in liver but not in erythroid tissue (Strand et 
al, 1972; Bottomley et al, 1973). Further assessment of ALA 
utilisation was carried out using 130 pmol [^^C]-ALA.
2.12.1 The effect of succinylacetone on ALA utilisation 
The effect of succinylacetone on ALA utilisation was assessed by 
adding 0.005 uCi (130 pmol) [^^C]-ALA to 50 x 10^ homogenised bone 
marrow cells in 0.5 ml incubation medium (Tikerpae et al, 1981) 
containing succinylacetone but no EDTA. The effect was compared 
with the ALA utilisation that occurred with incubation medium 
containing EDTA 10 mM but no succinylacetone. The marrow 
homogenate concentration used was high (50 x 10^ bone marrow 
cells/0.5 ml) to ensure significant ALA utilisation in the absence 
of succinylacetone.
With incubation medium containing EDTA (10 mM) 70% utilisation 
occurred at 60 min. In the absence of EDTA ALA utilisation was 
completely inhibited by succinylacetone ^ 0.01 mM (Fig 8).
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Note: ALA utilisation was assessed by adding 130 pmol ,
[ ^ C ] - A L A  to bone marrow homogenate (30 x 10^ cells) 
in 0.5 ml incubation medium (see text). Each point 
represents the mean of two observations.
Figure 8 : The effect of succinylacetone on
ALA utilisation
2.13 CALCULATION OF RESULTS
With each assay ALA recovery samples were run in parallel so that 
the peak height corresponding to 100% recovery of the internal 
standard might be calculated.
2.13.1 Control tubes
( The cpm in the ALA pyrrole region resulting from contaminating
2-keto[-^C]glutarate, [-^C] -succinate or radioactive metabolites 
were determined for each batch of samples assayed. Control tubes 
contained radioactive substrate incubated with bone marrow either 
for zero time and treated as described, or for 60 min at 37°C 
without the subsequent addition of ethylacetoacetate.
2.13.2 Enzyme activity calculation
II For each individual sample assayed, the cpm in the ALA pyrrole 
region was corrected for background and for 100% recovery. For
those few samples in which ALA synthase activity was measured in
the absence of succinylacetone, further correction for ALA 
utilisation was required.
l ^
I • ? 'f The ALA synthase activity m  each /eppmdorf was calculated from
the formula
£ jr Corrected cpm in ALA pyrrole
pmol ALA/eppindorf/h =_______________________ _________
cpm/pmol [l^C]-substrate 
Enzyme activity was then related either to the total cell count or 
to the erythroblast content of each sample.
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2.14 PREPARATION OF TISSUES
2.14.1 Sonication procedure
The optimum sonication procedure for the recovery of ALA synthase 
activity was determined using 2-keto[^^C]-glutarate (0.17 mM) with 
incubation medium optimised for use with this substrate (Tikerpae 
et al, 1981). Sonication was carried out in the small plastic 
tubes used by the Kemtek 3000 autoanalyser for radioimmunoassay 
analysis in many departments of Medical Biochemistry in this 
country.
120 x 10  ^ bone marrow cells were obtained at sternotomy. The 
cells were washed and pellets of 20 x 10  ^ cells were prepared in 
six individual Kemtek tubes. Incubation medium (1.5 ml) was added 
to each tube. The tubes were placed in ice and the cells were 
distributed using a MSE 150 KW ultrasonic disintegrator fitted 
with a 1/8" titanium probe. Amplitude was set to 15 microns in 
air which dampened to 12 microns in incubation medium.
The reaction was terminated at 60 min and the samples treated as 
described. ALA synthase activity per ^pp^ndorf was calculated.
The optimum sonication procedure was 3 x 5 '  pulses (Fig 9). The 
activity recovered with one 15 sec pulse of sonication (not shown) 
was 30% less than that found after 3 separate pulses of 5 sec.
The latter procedure was chosen for routine use.
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ALA synthase activity was assessed using 
2~keto[^C]glutarate. Each point represents 
the mean of two observations.
Figure 9 : The effect of ultrasonication on ALA
synthase activity in human bone marrow
2.14.2 The effect of deoxvcholate
Aoki et al (1974) reported increased ALA synthase activity when
. . •bone marrow was prepared using a combination of sonication and
S' .
membrane solubilisation with deoxycholate. Deoxycholate 0.5% was
m4r*4'rf‘
added to incubation medium prior' to sonication and enzyme activity
Vi*'' /
was determined using both 2-keto[l^C]-glutarate (0.17 mM) and
/
[14C] -succinate (2.0 mM). The incubation medium for
[14C] -succinate contained an exogenous succinyl CoA generating
system (MgCl2 20 mM, GTP 2.5 mM, STK 0.5 U, final pH 7.4 at 37°C).
The addition of 0.5% deoxycholate to the incubation medium 
abolished ALA synthase activity with both succinate and
w .e£ 2-ketoglutarate. This was not due to a pH effect which remained
/
unchanged at 7.4 with deoxycholate. No further experiments with 
membrane solubilisation were attempted and the method of sample 
preparation with sonication alone adopted for future use was as 
follows.
1. Prepare the marrow cell pellet in Kemtek tube.
2. Remove supernatant and add 1.5 ml incubation medium.
3. Pack tube in ice.
4. Disrupt cells using MSE 150 KW ultrasonic disintegrator.
Set amplitude to 15 microns in air and apply 3 x 5  sec
pulses.
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2.15 CHOICE OF f14Cl-SUBSTRATE
2.15.1 Use of 2-ketoelutarate dehydrogenase 
2-ketoglutarate dehydrogenase was obtained from Sigma Chemical
S'
Company and was tested for its suitability for use in the assay of 
ALA synthase using 2-keto[*^C]glutarate. Incubation medium 
(Tikerpae et al, 1981) containing NAD (1 mM) was used to allow 
conversion of 2-ketoglutarate to succinyl CoA (see section 2.4.1).
To examine this commercial enzyme preparation for contaminating 
ALA synthase activity, enzyme solution (0.5 U) was incubated with 
2-keto[l^C]glutarate (0.17 mM, specific activity 6 Ci/mol) in NAD 
supplemented incubation medium. A control eppindorf without 
2-ketoglutarate dehydrogenase was run in parallel.
The cpm in the ALA pyrrole fractions from the control sample was 
20 cpm. In the test sample however the total cpm in the ALA 
pyrrole region was 2,200 cpm. This suggested that the enzyme 
preparation contained ALA synthase activity. As a result no 
further experimentation with 2-ketoglutarate dehydrogenase was 
attempted.
2.15.2 r^Cl-{Succinate V^s 2-keto[^Clglutarate
< ) [^C]-Succinate an<j 2-keto[^C]glutarate were examined to
determine the more suitable substrate for use in the assay of bone 
marrow ALA synthase.
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Optimum conditions for the measurement of enzyme activity with 
2-keto[^C]glutarate were used. Incubation medium was that 
described by Tikerpae et al (1981) with a .final concentration of 
0.17 mM 2-keto[^c]glutarate (specific activity 
6 Ci/mol). Incubation medium for [^^C]-succinate (specific 
activity 3.0 Ci/mol), at a final concentration 2 mM, was 
supplemented with an exogenous succinyl CoA generating system 
containing MgCl£ 20 mM, GTP 2.5 mM and STK 0.5 U.
ALA synthase activity detected with 2-keto[^C]glutarate was 
200 pmol ALA/10^ erythroblasts/h and with [^C]-succinate was 
440 pmol ALA/10^ erythroblasts/h. Control counts were 3 x above 
background with [^^C]-succinate and 2 x above background with 
2-keto[l^C]glutarate. This reflected the fivefold greater cpm 
added as [l^C]-succinate than as 2-keto[^C]glutarate.
These results indicate that under conditions optimised for 
2-keto[l^C]glutarate, the use of [^C]-succinate with minor 
modifications to the incubation medium had doubled the sensitivity 
of the assay. Similar results have been reported with the study 
of hepatic ALA synthase (Ebert et al, 1970). In view of theae 
findings and the relative ease with which commercial high purity 
STK may be obtained, [l^C]-succinate was used for all future 
experiments.
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2.15.3 Use of STK
There are two available commercial preparations of STK. Both are 
GTP dependent, require Mg++ as cofactor and are prepared from 
porcine heart. The preparation from Sigma is available as a 
lyophilised powder whereas that from Boehringer Mannheim is an 
enzyme suspension in saturated ammonium sulphate.
Under identical conditions, in incubation medium containing MgCl2 
20 mM and GTP 2.5 mM, 0.5 U of STK in ammonium sulphate was shown 
to reduce ALA synthase activity to 70% of that found with 
lyophilised STK resuspended in incubation medium. It was felt 
likely that this reduction in enzyme activity resulted from the 
addition of saturated ammonium sulphate.
STK 0.5 U (Sigma) was added to incubation medium (0.5 ml) 
containing MgCl2 20 mM, GTP 2.5 mM and [^C]-succinate 2 mM 
(specific activity 3 Ci/mol). The mixture was incubated for 
60 min at 37°C. The presence of STK in the incubation medium did 
not increase the cpm in the ALA pyrrole beyond the background cpm 
of a similar sample incubated without STK. This indicated that 
STK (Sigma) was free of ALA synthase activity and this preparation 
was used for all further experiments.
2.16 OPTIMUM CONDITIONS FOR THE MEASUREMENT OF BONE MARROW ALA 
SYNTHASE ACTIVITY USING r14Cl-SUCCINATE
The optimum concentration of reagents in the incubation medium was 
determined for maximum ALA synthase activity with [l^C]-succinate
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as substrate. In particular it was decided (i) to examine the 
need for exogenous STK; (ii) to optimise the concentration of EDTA 
and succinylacetone such that ALA utilisation might be inhibited 
without loss of ALA synthase activity; (iii) to determine the 
optimum concentrations of [l^Cl-succinate, CoA and GTP; and 
(iv) to assess the need for citric acid cycle inhibitors in the 
medium. As the conversion of succinate to succinyl CoA requires 
v / free Mg++ MgCl2^20 mM^)was added to the medium.
2.16.1 Need for exogenous STK
The addition of STK 0.5 U to bone marrow homogenate in incubation
medium containing MgCl2 20 mM, CoA 1.35 mM and GTP 5.0 mM produced
a 10% increase in ALA synthase activity (Figure 10).
2.16.2 Optimum concentrations of CoA. GTP. STK
The concentrations of CoA and GTP were altered with the pH
maintained at 7.4 at 37°C. Marrow homogenate was incubated in 
medium containing sucrose 250 mM, glycine 50 mM, GTP 2.5 mM, MgCl2 
20 mM, EDTA 10 mM, PLP 0.4 mM, Tris 40 mM buffered to pH 7.4 at 
37°C with KH2PO4 50 mM and STK 0.5 U in a final volume of
0.5 mol. The concentration of added CoA ranged from 0-1.35 mM
with pH maintained at 7.4 at 37°C. ALA utilisation was calculated 
as described (section 2.12).
Maximum ALA synthase activity was found with CoA 1.35 mM (Fig 11).
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Figure 11: The effect of CoA concentration on
ALA synthase activity
Three separate GTP concentrations were tested to determine the 
optimum GTP concentration in the incubation medium containing CoA 
1.35 mM.
Maximum ALA synthase activity was found with GTP 5 mM (Fig 12) .
In the final group of experiments the combined optima for GTP, CoA 
and STK were determined. CoA, GTP and STK concentrations were 
altered with the pH maintained at 7.4 at 37°C. ALA synthase 
 ^ activity was determined in eppindorfs each containing
r
approximately 15 x 10^ bone marrow cells (Table 1).
The optimum combination of reagents for the detection of ALA 
synthase activity in human bone marrow was GTP 5.0 mM CoA 1.35 mM 
and STK 0.5 U in a final vol of 0.5 ml.
2.16.3 The effect of EDTA and succinvlacetone on ALA synthase 
activity
Succinylacetone was shown to completely inhibit ALA utilisation 
(section 2.12.1). The effect of both EDTA and succinylacetone on 
ALA synthase activity was determined with a view to abolishing ALA 
utilisation without loss of ALA synthase activity.
Incubation medium contained glycine 50 mM, MgCl£ 20 mM, sucrose 
250 mM, PLP 0.4 mM, CoA 1.35 mM, GTP 5 mM, Tris 40 mM buffered 
with KH2PO4 50 mM to pH 7.4 at 37°C and 0.5 U STK in a final 
volume of 0.5 ml. The effect of EDTA 10 mM and succinylacetone
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Figure 12: The effect of GTP concentration on
ALA synthase activity
SAMPLE CoA 
(mM)
GTP
(mM)
STK 
(U/0.5 ml)
ALA SYNTHASE 
(pmol ALA/Eppindorf/h
1 0.65 2.5 0.5 3078
2 0.65 2.5 1.0 3098
3 0.65 5.0 0.5 3647
4 0.65 5.0 2.0 3507
5 1.35 2.5 1.0 3589
6 1.35 2.5 1.0 3642
7 1.35 5.0 0.5 4073
8 1.35 5.0 1.0 3933
NOTE: Incubation conditions are described in the text.
TABLE 1: The effect of CoA, GTP and STK
on ALA synthase activity
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0.1 mM was assessed with three marrow samples, two were taken from 
normal subjects and one from a patient with chronic lead poisoning 
(free erythrocyte protoporphyrin 360 ug/100 ml packed cells, 
normal < 90, whole blood lead 45 ug/100 ml, normal < 40). From 
each bone marrow sample three identical cell pellets were prepared 
and assayed for ALA synthase activity in the presence of
a) 0.1 mM Succinylacetone, zero EDTA
b) 0.1 mM Succinylacetone, 10 mM EDTA
c) Zero Succinylacetone, 10 mM EDTA
In the absence of succinylacetone ALA utilisation was calculated 
as described (section 2.12).
The results are shown in Figure 13. Neither EDTA 10 mM nor 
succinylacetone 0.1 mM, separately or together, were shown to 
inhibit ALA synthase activity and both were chosen for routine use.
2.16.4 Optimum succinate concentration
The optimum concentration of [^^C]-succinate for the measurement 
of bone marrow ALA synthase activity was determined.
Normal marrow homogenate was incubated with different 
concentrations of [^^C]-succinate under identical conditions. The 
incubation medium contained glycine 50 mM, sucrose 250 mM, MgCl2 
20 mM, EDTA 10 mM PLP 0.4 mM, CoA 1.35 mM, GTP 5 mM, 
succinylacetone 0.1 mM, Tris 40 mM buffered to pH 7.4 at 37°C with 
KH2PO4 50 mM and STK 0.5 U in a final volume of 0.5 ml.
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Figure 13; The effect of~succinylacetone and EDTA 
on ALA synthase activity
The saturating level of succinate for maximal ALA synthase 
activity was 2 mM (Fig 14) and this concentration was chosen for 
routine use.
2.16.5 Effect of cell number and incubation time on ALA synthase 
activity
The effect of cell number in the bone marrow homogenate was 
determined. Enzyme activity was measured under the conditions 
described (section 2.16.4). Succinylacetone was omitted and ALA 
utilisation was calculated (see section 2.12).
The results show (Fig 10) that ALA synthase activity expressed as
] r" c/pmol ALA formed per epp'indorf at 60 min was linear with homogenate 
concentration from 0.2-36 x 10^ bone marrow cells per 0.5 ml.
Each point on Figure 10 represents a single observation as 
v duplicate (eppindorfs were used to demonstrate the increase m  
enzyme activity apparent with the addition of STK (0.5 U).
Enzyme activity was also shown to be linear with time and the 
activity present at 60 min was twice that present at 30 min.
Under the conditions described ALA synthase activity was shown to 
be linear both with time and homogenate concentration. Such an 
effect is likely to indicate measurement of ALA synthase activity 
under optimal conditions (Patton and Beattie, 1973).
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Note: Incubation was carried out for 60 min at 37°C in the
presence of glycine (30 mM), sucrose (230 mM), EDTA 
(10 mM), PLP (0.4 mM), MgCl2 (20 mM), GTP (5 mM),
CoA (1.35 m M ) , succinylacetone (0.1 mM) and STK (0.5 U) 
in a final volume of 0.5 ml. Each point represents the 
mean of two observations.
Figure 14: The effect of ['^C] succinate concentration
on ALA synthase activity
2.16.6 The effect of citric acid cycle inhibitors on ALA
synthase activity 
The effect of sodium malonate (10 mM) and sodium Dl-malate (5 mM) 
on ALA synthase activity in normal bone marrow was examined.
The addition of these inhibitors did not alter the pH of the 
incubation medium but did not increase ALA synthase activity.
Added separately they reduced enzyme activity by 40% with a 60% 
reduction when added together. The results are similar to those 
found by Ebert et al (1970) with the study of liver and spleen 
enzyme.
2.16.7 Reproducibility
The standard error of twelve duplicate estimates was derived from 
the residual error in a one-way analysis of variance from the 
natural logarithm of the individual estimates. This type of 
analysis was used by Cotes and Brozovic (1982) and may be applied 
to look at the intrinsic variability of a measurement after that 
due to inter-subject variation has been "removed" statistically.
It was felt that as the enzyme activity in normal marrow covered a 
wide normal range such an analysis would be more valuable than the 
coefficient of variation. It was shown that within 95% confidence 
limits the variation between duplicate samples was < 5%.
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2.17 SUMMARY
2.17.1 Optimum conditions for the assay of bone marrow ALA 
synthase activity 
Sample preparation:
Wash bone marrow cells x 3 in cold culture medium (centrifugation 
1500 gav and 4°C). Resuspend the cell pellet in fresh incubation 
medium (1.5 ml) and disrupt the cells using a MSE 150 KW 
ultrasonic disintegrator fitted with 1/8” titanium probe.
Maintain the sample temperature at 4°C during sonication with ice 
packing, set the amplitude to 15 microns in air and apply 
3 x 5  sec pulses of sonication.
Preparation of incubation medium:
Prepare incubation medium in part and store in batches at -20°C 
) until use. Prepare tetrasodium EDTA (10 mM) sucrose (250 mM) MgCl^ 
(20 mM), glycine (50 mM) and Tris (40 mM) in a final volume of 1 
litre (pH 8.0 at 37°C). Divide this solution and add KH2PO4 
(50 mM) to 500 ml. Add aliquots of this acid solution to the 
original 500 ml until the pH is 7.54 at 37°C. (This pH may be 
achieved by the addition of 370 ml of KH2PO4 buffered medium).
Store this preparation in 20 ml aliquots at -20°C until required.
Prepare 20 mM [^^C]-succinate (specific activity 3 Ci/mol) in this 
medium and store in aliquots of 210 ul at -20°C.
The assay:
On the day of the assay thaw an aliquot of incubation medium and 
add CoA (1.5 mM), GTP (5.6 mM), PLP (0.45 mM) and succinylacetone
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(0.11 mM). Resuspend the marrow cell pellet (1.5 ml) and 
lyophilised STK (0.5 U/25 jil (Sigma) in this fresh medium.
Add 50 jul [^C]-succinate (20 mM), 425 jal of marrow homogenate and 
25 ul STK solution to each (eppindorf. Incubate at 37°C for 60 min 
and assay each sample in duplicate. The final medium (0.5 ml) 
contains glycine 50 mM, Sucrose 250 mM, MgCl£ 20 mM, EDTA 10 mM, 
PLP 0.4 mM, STK 0.5 U, GTP 5 mM, CoA 1.35, succinylacetone 0.1 mM, 
Tris 40 mM and KH2PO4 20 mM, pH 7.4 at 37°C.
2.18 APPENDIX TO EXPERIMENTAL AND RESULTS
2.18.1 Storage of bone marrow samples
Bone marrow samples were either assayed fresh for ALA synthase 
activity or after storage as cell pellets at -70°C. Under these 
conditions ALA synthase activity was stable for at least six 
months.
2.18.2 Purity of commercial [-^Cl-ALA
At the completion of this work a method was devised to check the 
purity of commercial [^^C]-ALA.
[1^C]-ALA stored at -20°C for a total of two years (a further year 
after the completion of the experimental work) was examined. 
Approximately 1.2 nmol [1^C]-ALA was added to 0.5 ml incubation 
medium containing 200 nmol cold ALA (identical to that used as 
internal standard). ALA pyrrole was formed as described and the 
volume made to 5.0 ml with water. From this solution 0.5 ml was
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diluted 1 in 5 with water and reacted with an equal volume of 
modified Ehrlich reagent. The OD at 555 nm was 0.32.
From the formula
OD
Conc(M) =  ;___________________
Extinction coefficient (M)
it was determined that there had been 100% conversion of cold ALA 
to ALA pyrrole. 1.0 ml of this solution was taken for 
scintillation counting and the remainder injected through an 
activated C18 Sep-pak cartridge. No ALA pyrrole was detected by 
reaction with Ehrlich's reagent in the Sep-pak eluate thereby 
indicating that all ALA pyrrole had been retained by the Sep-pak.
1.0 ml of eluate was taken for scintillation counting.
Despite the absence of detectable ALA pyrrole in the eluate, 20% 
of the original cpm were recovered m  this fraction. These cpm
did not represent unconverted [1^C]-ALA. 1.0 ml of this fraction
!
■ was reheated to 100°C for 20 min with 0.1 ml ethylacetoacetate.
On cooling, no ALA pyrrole was detected with Ehrlich reagent.
ALA pyrrole was eluted from the Sep-pak with methanol (3.5 ml).
An aliquot of methanol was diluted 1 in 5 with water and reacted 
with 1.0 ml of modified Ehrlich reagent. The OD was 0.32 at 
555 nm and this indicated complete recovery of cold ALA pyrrole.
1.0 ml of methanol was taken for scintillation counting; the 
remainder was evaporated to dryness and resuspended in 0.1 ml 50%
 ^ (v/v) aqueous methanol from which 0.05 ml was taken for RPHPLC.
The cpm were determined in 30 sec fractions of HPLC column eluate.
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The remaining 80% of the original cpm were recovered from the 
Sep-pak in the methanol and were shown by RPHPLC to represent 
[14c ]-ALA pyrrole.
These results indicate that after two years' storage the [1^C]-ALA 
was only some 80% pure. This was simply shown by demonstrating 
20% of the original cpm in the Sep-pak eluate, which did not 
contain either ALA or ALA pyrrole. RPHPLC confirmed that the cpm 
retained by Sep-pak were as [1^C]-ALA pyrrole.
The producers of the [1^C]-ALA (Amersham International) were 
informed. Some two months after the purchase of the radiochemical 
their own re-testing had identified the batch to be 93.7% pure.
The particular batch was withdrawn. Further deterioration to 80% 
within the next two years is more than would be expected from the 
accompanying information on [1^C]-ALA from Amersham. The company 
now feels that their prediction of 4% deterioration per annum is 
not realistic and will amend their product information accordingly.
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DISCUSSION
There is no doubt but that the most significant feature of the 
developed assay method is the simple and specific technique 
described to isolate [l^Cj-ALA pyrrole. The introduction of a 
sample preparation step using a Sep-pak cartridge obviated the 
need for ether extraction and freeze drying prior to RPHPLC 
(Tikerpae et al, 1981) and circumvented the problems relating to 
the specific isolation of [^^C]-ALA (Bishop and Wood, 1977; Minaga 
et al, 1978; Wolfson et al, 1980; Scotto et al, 1983). The 
Sep-pak facilitated the isolation of pure ALA pyrrole by RPHPLC, 
for which an ion-pairing agent and a Cl8 column were used to 
provide maximum resolving power for the hydrophobic ALA pyrrole. 
Low background counts in the controls samples indicated that the 
combination of Sep-pak and RPHPLC achieved separation of ALA 
pyrrole from radioactive succinate, contaminants in commercial 
[ 14c] -succinate and metabolites. This separation procedure 
allowed the addition of internal standard to each individual 
sample and eliminated the problem of variable ALA recovery 
associated with multicolumn ion exchange fractionations (Schacter 
et al, 1976). TCA was added to stop the reaction, centrifugation 
removed precipitated protein and sodium acetate was added to 
adjust the pH to 5.3. ALA was converted to ALA pyrrole which was 
bound to a C18 Sep-pak cartridge prior to RPHPLC.
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Utilisation of ALA formed during incubation in the presence of 
EDTA does not occur with liver (Ebert et al, 1970; Strand et al, 
1972) but is a recognised problem with the assay of erythroid ALA 
synthase (Strand et al, 1972; Bottomley et al, 1973). This 
observation was confirmed and utilisation was shown to be linear 
with bone marrow cell number up to 40 x 10^/0.5 ml (Fig 7). There 
was no evidence to support the report of disproportionate ALA 
utilisation at high marrow homogenate concentration (Bottomley et 
al, 1973) or of inhibition of ALA synthase activity by 10 mM EDTA 
(Strand et al, 1972).
Succinylacetone 10”  ^M was shown to inhibit ALA utilisation 
(Fig 8) and was used at 10”^ M in the incubation medium to inhibit 
utilisation without loss of ALA synthase activity 
(Fig 13). This effect suggests that ALA utilisation during the 
assay of erythroid ALA synthase results from incomplete inhibition 
of ALA dehydratase by EDTA and not from alternative metabolism 
which might lead to the transamination of ALA and formation of y<5 
dioxovaleric acid (Tait, 1969) or from non enzymatic degradation 
of ALA. The presence of succinylacetone during incubation removed 
the need to measure and correct for ALA utilisation and so reduced 
(halved) the number of samples required in each assay and improved 
precision.
5)
[14C]-succinate was shown to be more sensitive to bone marrow ALA 
synthase than 2-keto[^^C]glutarate; an observation already
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reported with liver homogenate (Ebert et al, 1970). The method 
described for measurement of bone marrow ALA synthase was 
optimised with respect to sonication procedure ALA pyrrole 
production, succinate, CoA, GTP, STK, EDTA and succinylacetone 
concentrations to obtain maximum ALA synthase activity. The 
reaction was shown to be linear with time over 60 min and with 
cell number up to 36 x 10^ bone marrow cells per 0.5 ml. It was 
capable of detecting enzyme activity in as little as 2 x 10  ^bone 
marrow cells (5 x 10^ erythroblasts) (Fig 10) and was shown to be 
highly reproducible. The optimum conditions established for the 
measurement of bone marrow ALA synthase differ from those which 
are required for maximum liver enzyme activity (Irving and 
Elliott, 1969; Ebert et al, 1970; Strand et al, 1972). This would 
be expected as it has been recognised that problems may arise when 
an ALA synthase assay developed with one tissue is applied without 
modification to detect enzyme activity in a different tissue 
(Condie and Tephly, 1978). Optimum conditions for the measurement 
of liver ALA synthase have been shown to be suboptimal for adrenal 
or cardiac enzyme. Furthermore chromatographic separation 
techniques also require to be ascertained and modified for use 
with different tissues (Briggs et al, 1976; Condie et al, 1976).
The addition of citric acid cycle inhibitors sodium malonate 
(10 mM) and sodium malate (5 mM) reduced ALA synthase activity. 
This was unexpected but has been reported with the assay of the 
liver enzyme (Ebert et al, 1970). There would seem to be two
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possible explanations. Either malonate and malate inhibited ALA 
synthase or they effected a dilution of the [l4C]-succinyl CoA 
pool with cold succinyl CoA. The effect of arsenite on marrow ALA 
synthase activity was not tested in view of the toxicity hazard 
(Muir, 1977) and the reported 41% inhibition of ALA synthase 
activity by 5 mM arsenite (Ebert et al, 1970). Inhibition of 
2-ketoglutarate dehydrogenase without loss of significant ALA 
synthase activity would be desirable, as it would indicate whether 
the reduction in ALA synthase activity in the presence of malate 
and malonate had resulted from increased synthesis of cold 
succinyl CoA or from inhibition of ALA synthase. Although Ebert 
et al (1970) felt that the former hypothesis was not likely, 
future experiments with citric acid cycle inhibitors may explain 
these observations.
The determination of ALA synthase activity in radiochemical assays 
is dependent upon the purity of commercial [1^C]--ALA used to 
determine ALA recovery. In this assay it was used to calculate 
the peak height equivalent to 100% recovery. Problems with the 
purity of commercial [^^C]-ALA are recognised by other workers and 
by the manufacturers. It would seem as if the purity of the 
[14C]-ALA used for the work reported here was about 90%. This 
would make no material difference to the results recorded. The 
description of a method to determine the purity of commercial 
[14C]-ALA, ensures that the manufactuers claims of purity and 
stability may now be examined both rapidly and simply before they 
are accepted.
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CHAPTER 3
5-AMINOLAEVULINIC ACID SYNTHASE ACTIVITY 
IN UNFRACTIONATED HUMAN BONE MARROW
3. 5-AMINOLAEVULINIC ACID SYNTHASE ACTIVITY 
IN UNFRACTIONATED HUMAN BONE MARROW
From microscopic examination it is evident that bone marrow is a 
dynamic continuously developing tissue, composed of cells from 
different lineages, at different stages of differentiation. The 
major cell lines are myeloid and erythroid with lesser numbers of 
lymphocytes, plasma cells, monocytes, histiocytes and 
megakaryocytes. The ratio of myeloid: nucleated erythroid cells 
is known as the M:E ratio which in normal marrow ranges from
2.5 - 15:1 (Dacie and Lewis, 1975). In the presence of erythroid 
hyperplasia there is a reduction or a reversal of the normal M:E 
ratio. In practice, adult marrow is readily accessible and may be 
aspirated from the anterior/posterior iliac crests or from the 
sternum in relatively small volumes. Large volumes are more 
difficult to obtain as aspiration of more than 0.3 ml leads to 
dilution of the marrow sample with peripheral blood (Dacie and 
Lewis, 1984).
Bone marrow is the major iron utilising and haem producing tissue 
in the body (Berk et al, 1976) from which hypochromic microcytic 
red cells originate in response to iron and so haem deficient 
erythropoiesis. All mammalian cells apart from mature red blood 
cells synthesise haem. The myeloid cells in bone marrow are no 
exception and are rich in haem containing enzymes, peroxidase,
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catalase and mitochondrial cytochromes. Peroxidase is most 
abundant and represents some 5% of the total dry weight of the 
polymorphonuclear leucocyte (Suzuki et al,. 1983). It is then 
clear that although erythroid cells are the major haem forming 
cells and manifest the effects of haem deficiency most clearly, 
they are not the only haem producing cells in the marrow.
Visual evidence of haem synthesis in bone marrow is most apparent 
from the development of haemoglobin in erythroid cells. During 
erythropoiesis there is a parallel progression of 
haemoglobinisation and differentiation. Haemoglobin is not 
evident in the early basophilic erythroblasts, its presence may be 
detected in the intermediate polychromatic erythroblasts, while in 
the late orthochromatic forms it packs the cytoplasm as if to 
squeeze the small pyknotic nucleus from the cell. There is 
considerable interest as to what factors regulate the synthesis of 
erythroid haem and what factors are regulated by synthesised 
haem. It is thought that free haem may have a central role in the 
regulation of protein and globin synthesis, in other aspects of 
cell metabolism such as iron uptake and also in the control of the 
differentiation process itself (see Chapter 5). Although the role 
of ALA synthase as the rate limiting enzyme of hepatic haem 
biosynthesis has been identified (Granick and Urata, 1963) its 
place in the regulation of human erythroid haem synthesis is less 
certain (see Chapter 5). The level of haem synthetic activity 
within erythroid cells may be affected by two separate factors:
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firstly the level of cell differentiation and secondly the 
processes adapted for short term regulation and fine adjustment of 
haem synthesis in cells actively producing haem (Elder, 1981),
The short term regulation processes may themselves however also be 
affected by the level of differentiation: the presence of haem in 
early erythroblasts may serve to induce ALA synthase activity 
(Sassa, 1976; Elder, 1981; Ibrahim et al, 1983) while in 
reticulocytes haem has been shown to inhibit ALA synthase (Aoki et 
al, 1971; Ibrahim et al, 1978).
Although differentiation is likely to be the more important factor 
(Tait, 1978; Elder, 1981) a clear understanding of human erythroid 
haem biosynthesis has not yet emerged, as the heterogeneity of 
cells in bone marrow samples has restricted access to age matched 
human erythroblasts. As a result "in vivo" human erythroblasts 
have not been used to study the control of erythroid haem 
synthesis and ALA synthase activity. Investigations have been 
carried out in alternative erythroid systems: embryonic chick 
blastoderm (Levere and Granick, 1965), foetal hepatic 
erythroblasts (Freshney and Paul, 1971), mouse Friend 
erythroleukaemia cells (Sassa, 1976; Beaumont et al, 1984), "in 
vitro" mammalian bone marrow cultures (Ibrahim et al, 1982) and 
the human erythroleukaemia cell line K562 (Hoffman et al, 1980; 
Bottomley et al, 1985).
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3.1 UNFRACTIONATED BONE MARROW ALA SYNTHASE
As the techniques for human bone marrow fractionation and cellular 
isolation have only recently been described (Ali et al, 1983) the 
study of human bone marrow ALA synthase activity has so far been 
confined to the detection of enzyme activity in unfractionated 
marrow in normal and pathological states. Enzyme activity in 
these bone marrow samples has been thought to reflect only that 
present in the marrow erythroblasts. This untested belief has 
been used in all previous studies. The marrow enzyme activity has 
been related to the sample erythroblast content and the activities 
found in different samples have been compared, irrespective of 
differences in their M:E ratios.
In certain pathological conditions the erythroid population is 
left shifted ie, more immature, than that found in normal marrow. 
Despite evidence from the alternative erythroid systems indicating 
that erythroblast ALA synthase activity may be dependent on 
differentiation status, this has not been discussed in previous 
studies of unfractionated marrow ALA synthase activity (Bottomley 
et al, 1973; Aoki et al, 1974; Konopka and Hoffbrand, 1979; Manabe 
et al, 1982) and comparisons have been made between marrows 
without regard for the state of erythroblast development.
The measurement of ALA synthase activity in crude unfractionated 
marrow has not provided any useful information on the regulation 
of erythroid haem biosynthesis or the effect of erythroid iron and
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haem deficiency on ALA synthase activity (Aoki et al, 1974). It 
has however identified conditions in which there appears to be a 
reduction in bone marrow, and so by inference erythroid, ALA 
synthase. Reduced enzyme activity has been found in both 
congenital sideroblastic anaemia and PASA (Bottomley et al, 1973; 
Aoki et al, 1974; Konopka and Hoffbrand, 1979; Bottomley, 1980) 
and is now regarded as the primary metabolic defect in PASA and 
the likely cause of the ring sideroblastic defect (Aoki et al, 
1974; Ponka and Neuwirt, 1974; Bottomley, 1977, 1980, 1982; Aoki, 
1980).
3.2 AIM OF THIS STUDY
The purpose of the work described here was:
(1) to compare the developed assay of ALA synthase activity 
(Chapter 2) with published methods in normal and 
sideroblastic marrows;
(2) to examine the effect of M:E ratio on ALA synthase 
activity in normal marrows; and
(3) to assess the effect of erythroblast maturity on 
unfractionated marrow ALA synthase activity in 
sideroblastic and dyserythropoietic states.
3.2.1 Comparison of the developed assay with established assays 
ALA synthase activity in bone marrow has been shown to be 
dependent on the choice of radiochemical substrate, the method of 
sample preparation (Aoki et al, 1974) and the concentration of
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reagents in the sample incubation. It was aimed to compare 
results obtained with the method described in Chapter 2 with those 
of Aoki et al (1974), who using [14C] -succinyl CoA detected more 
enzyme activity than had been found with either
2-keto[-^C]glutarate (Bottomley et al, 1973; Tikerpae et al, 1981) 
or [14C] -succinate (Fraser and Schacter, 1980).
3.2.2 The effect of M:E ratio on ALA synthase activity in 
normal bone marrow
Myeloid cells, despite their content of haem enzymes have not been 
thought to contribute significantly to the ALA synthase activity 
found in unfractionated human bone marrow. If this is true a 
relationship between enzyme activity (per 10  ^ erythroblasts) and 
M:E ratio would not be expected. The effect of M:E ratio on ALA 
synthase activity was examined in 11 normal marrow samples.
3.2.3 The effect of erythroblast maturity
ALA synthase activity in marrow samples with a similar (but non 
ring sideroblastic) erythroid population was compared with that 
found in PASA.
In PASA the marrow appearances often reveal erythroid hyperplasia 
with a reduced M:E ratio. The erythroid precursors may show 
dyserythropoietic features and have a high degree of ineffective 
iron turnover and ineffective erythropoiesis (Singh et al, 1970). 
Intramedullary erythroblast lysis leads to a relative increase in
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the number of immature erythroblasts in the bone marrow. By 
comparison erythropoiesis in normal bone marrow is more effective 
and the four cell divisions between proerythroblast and late 
erythroblast ensure that the majority of erythroblasts are at a 
late stage of development (Harris and Kellermeyer, 1970),
Bone marrow ALA synthase activity in PASA was compared with that 
found in untreated megaloblastic anaemia, thalassaemia intermedia 
and congenital dyserythropoietic anaemia (CDA). Although 
heterogenous in their pathogenesis these disorders have in common 
with PASA a similar left shifted ineffective erythroid population 
and a reduced M:E ratio. They differed from PASA in that they 
were thought to be free of haem synthetic defects and were shown 
to lack the many visible ring sideroblasts seen with light 
microscopy in PASA.
MATERIALS AND METHODS
Bone marrow samples were taken from 11 normal volunteers and 11 
anaemic patients. The M:E ratios on the marrows studied were 
calculated from a 400 cell differential count carried out on 
marrow cell cytospin preparations.
64
3.3 NORMAL SUBJECTS
Haematological information on the 11 normal volunteers is given in 
Table 2. Eight subjects were having minor ENT surgery hut agreed 
to donate marrow, which was taken after the induction of general 
anaesthesia. Subjects 4, 5 and 6 (see Table 2) were 
haematologically normal but each had a thoracotomy with rib 
resection. Marrow was expressed from the rib immediately after 
resection. Patient 4 had a trans-thoracic hiatus hernia repair. 
Patient 5 had an opacity on chest x-ray which was found to be an 
arteriovenous fistula. Patient 6 had lung carcinoma confined to 
the thorax with no evidence of mestastatic spread. Bone marrow 
morphology was normal in all 11 patients.
3.4 THE ANAEMIC PATIENTS
Table 3 presents haematological information on the 11 anaemic 
patients studied.
3.4.1 Sideroblastic anaemia
Three patients with established PASA were studied. They were not 
transfusion dependent but showed ring sideroblastic change in more 
than 60% of their marrow erythroblasts. Blast cells were not 
evident and two of the patients remain stable, at 18 months after 
study. One patient died from a ruptured aortic aneurysm.
Patient 4 had congenital non pyridoxine response sideroblastic 
anaemia. He was an infant of six months who had an affected 
brother aged 5 years.
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Serum Transferrin ALA synthase
Hb ferritin saturation M:E (pmol ALA/10^
(g/dl) (ug/1) (%) Ratio erythroblasts/h)
1 M 14.8 234 25 3:1 762
2 F 13.2 175 15 3.5:1 890
3 M 15.4 61 30 4:1 630
4 M 14.3 120 20 4:1 706
5 M 16.8 101 55 4:1 745
6 F 13.6 16 21 4:1 775
7 F 13.0 91 18 5:1 835
8 M 15.9 234 25 8:1 821
9 M 16.2 81 30 8:1 1282
10 F 13.6 29 28 10:1 1200
11 F 12.9 12 24 10:1 1115
TABLE 2: The normal volunteers
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Serum Transferrin ALA synthase
Hb ferritin saturation M:E Cpmol ALA/10^
(g/dl) (ug/1) (%) Ratio erythroblasts/h)
1 M 9.1 307 50 1:1 320
2 M 8.1 219 50 2:1 370
3 M 8.7 1283 70 1:1 518
4 M 7.0 5000 100 4:1 400
5 F 7.4 169 100 1:1 922
6 F 6.7 92 50 1:1 1290
7 F 6.2 117 60 2:3 850
8 M 8.4 200 50 1:2 700
9 F 7.8 2490 100 1:2 280
10 M 10.1 572 100 3:2 450
11 M 10.0 758 70 1:2 250
NOTE: Patients 1-3 PASA; Patient 4 congenital
sideroblastic anaemia; Patients 5-7 megaloblastic 
anaemia; Patients 8 and 9 thalassaemia 
intermedia; Patients 10 and 11 CDA.
TABLE 3 : The anaemic patients
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3.4.2 Megaloblastic anaemia
Three patients with megaloblastic anaemia were studied. Two 
patients (5 and 6) had pernicious anaemia, diagnosed on the basis 
of reduced serum vitamin B-^2 levels, correction of an abnormal 
Schilling test by intrinsic factor and the presence of antibodies 
in serum to intrinsic factor. The third patient had simple 
dietary folate deficiency with no history of alcohol ingestion. 
Bone marrow reticuloendothelial iron stores were plentiful and 
serum ferritin concentrations were normal in the three patients. 
Ring sideroblasts were not seen and all three patients responded 
with a brisk reticulocytosis (> 10% on day 5) to haematinic 
replacement.
3.4.3 Thalassaemia intermedia
Two patients with thalassaemia intermedia were studied. One 
patient (8), a Vietnamese boat person had HbH disease and was a 
compound heterozygote for a°thalassaemia trait and Hb constant 
spring. The other patient (9) was a Greek immigrant with 
8 thalassaemia intermedia and a considerable degree of non ring 
sideroblastic marrow iron overload which had resulted largely from 
a transfusion programme required for some years prior to 
splenectomy in 1978.
Examination under light microscopy demonstrated considerable 
reticuloendothelial iron overload in patient 9, in whom 20%
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pathological and 5% ring sideroblasts were noted. Patient 8 had 
10% pathological and 2% ring sideroblasts.
3.4.4 CPA
Two patients with CDA were studied. One patient (10) had features 
of CDA type II; however, the acidified serum lysis test was 
negative with the serum of five normal subjects. Approximately 
10% of his marrow erythroblasts were either bi- or tri-nucleate 
and there was gross punctate basophilia. As with other cases of 
CDA (Weatherall et al, 1973) there was an imbalance of a : 8 
globin chain synthesis ratio, 1.96 (normal range 0.97 - 1.19). 
Ferrokinetic studies indicated a seven fold increase in marrow 
iron turnover with 85% ineffective erythropoiesis. Hb 
electrophoresis was normal, HbF 2.2%. The second patient (11) had 
an atypical form of CDA with features similar to those described 
by Hruby et al (1973). The marrow showed erythroid hyperplasia 
with gross dyserythropoiesis, punctate basophilia and 2% 
binucleate forms. The acidified serum lysis test was negative and 
HbF was elevated at 17.6%. (Hb A£ 3.6%). There was minimal 
hypochromia (MCV 80 fl, MCH 26.5 pg), ferrokinetic evidence of 90% 
ineffective erythropoiesis and a :nona globin chain synthesis 
ratio of 2 :1.
Both patients with CDA showed considerable reticuloendothelial 
marrow iron overload on light microscopy with 20% pathological and
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8% ring sideroblasts in patient 10 and 5% pathological and 2% ring 
sideroblasts in patient 11.
3.5 ALA SYNTHASE ACTIVITY
ALA synthase activity was determined as described and was related
to the sample erythroblast content to allow comparison with 
previous studies. For the 11 normal marrows enzyme activity was 
also related to the M:E ratio.
RESULTS
The results of ALA synthase activity in the normal and
pathological marrow samples studied are shown in Tables 2 and 3
and Figure 15.
3.6 ALA SYNTHASE ACTIVITY IN NORMAL UNFRACTIONATED HUMAN BONE 
MARROW
The mean ALA synthase activity in 11 normal marrow samples was 
893 pmol ALA/10^ erythroblasts/h (range 630-1282, S.D. +_ 199). 
Enzyme activity was related to the M:E ratio and was significantly 
higher in those samples with a ratio of more than 4:1 (p = 0.03) 
(Table 4).
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ALA synthase activity was related to the erythroblast 
content of the marrow samples.
Figure 15: ALA synthase activity in unfractionated
human bone marrow
Number of M:E Mean ALA synthase activity (+. 1SD)
samples ratio (pmol ALA/10^ erythroblasts/h)
6 « 4:1 751 ( + 86)
5 > 4:1 1051 (+ 212)
TABLE 4 : The effect of M:E ratio on ALA synthase
activity in normal human bone marrow
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3.7 ALA SYNTHASE ACTIVITY IN ABNORMAL UNFRACTIONATED HUMAN
BONE MARROW
ALA synthase activity was reduced in the four patients with 
sideroblastic anaemia. In the three patients with megaloblastic 
anaemia and in one patient with thalassaemia (8), enzyme activity 
was found to be in the normal range. The other patient with 
thalassaemia (9) and both cases of CDA had low levels of ALA 
synthase activity.
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DISCUSSION
Mean ALA synthase activity in 11 normal marrow samples was 
893 pmol ALA/10^ erythroblasts/h (range 630 - 1282). This 
activity is approximately 50% greater than that found by Aoki et 
al (1974) and at least twice the mean activities reported by other 
investigators (Takaku and Nakao, 1971; Bottomley et al, 1973; 
Konopka and Hoffbrand, 1979; Fraser and Schacter, 1980; Tikerpae 
et al, 1981). The method has been shown to be highly sensitive, 
capable of detecting ALA synthase activity in 0.2 x 10^ bone 
marrow cells (section 2.16.5). The high sensitivity has resulted 
from the determination of optimum sample preparation and reagent 
concentration. This has allowed the detection of higher enzyme 
activity than has been previously reported in normal marrow 
samples. The performance of the assay may also indicate that 
RPHPLC is superior to the alternative methods available for ALA 
isolation.
In the normal marrow samples there was a positive relationship 
between ALA synthase activity and the M:E ratio. Similarly a 
positive relationship for coproporphyrinogen oxidase activity and 
M:E ratio in human bone marrow was shown by Elder and Evans 
(1975). These results suggest that myeloid cells may contain ALA 
synthase and coproporphyrinogen oxidase and so may contribute to 
the enzyme activities found in unfractionated marrow which should 
no longer be regarded only as a measure of erythroblast enzyme 
activity.
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ALA synthase activity was shown to be reduced in the sideroblastic 
marrow samples, a finding in keeping with numerous previous 
studies (see Bottomley et al, 1973; Aoki et al, 1974; Konopka and 
Hoffbrand, 1979). In the three cases of megaloblastic anaemia, 
mean enzyme activity per 10  ^ erythroblasts/h (1020 pmol) was more 
than twice the mean activity found in the three cases of PASA 
(402 pmol). It is clear that despite their similar level of 
erythroblast maturity and M:E ratio, ALA synthase activity is very 
much less in PASA than megaloblastic marrow (p < 0.5). Unless 
myeloid ALA synthase activity is sufficiently elevated in 
megaloblastic anaemia to account for this difference it may be 
inferred that megaloblasts have more ALA synthase activity than 
sideroblasts. It has been shown that normoblasts and megaloblasts 
of comparable maturity have similar levels of porphyrin synthesis 
(Dresel and Falk, 1954), similar levels of iron uptake (Lajtha and 
Suit, 1955) and similar levels of RNA synthesis (Hoffbrand and 
Wickramasinghe, 1982). If similar levels of ALA synthase activity 
are assumed, then both normoblasts, as well as megaloblasts would 
have more ALA synthase activity than sideroblasts. Erythroblast 
ALA synthase activity is the subject of Chapter 5.
One patient with thalassaemia intermedia had a level of marrow ALA 
synthase activity within the normal range despite gross erythroid 
hyperplasia and reversal in the M:E ratio (and presumably low 
myeloid ALA synthase). In thalassaemia patient (9) with some 
degree of transfusional iron overload and in both cases of CDA
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reduced levels of unfractionated marrow ALA synthase activity were 
found. This is the first report of reduced marrow enzyme activity 
in the absence of prominent ring sideroblastic change and will be 
discussed in relation to erythroblast ALA synthase activity in 
Chapter 5.
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CHAPTER 4
THE CALCULATED PERCENTAGE MYELOID-DERIVED 
5-AMINOLAEVULINIC ACID SYNTHASE ACTIVITY IN 
NORMAL AND SIDEROBLASTIC BONE MARROW
4. THE CALCULATED PERCENTAGE MYELOID-DERIVED
5-AMINOLAEVULINIC ACID SYNTHASE ACTIVITY IN 
NORMAL AND SIDEROBLASTIC•BONE MARROW
The relationship demonstrated between M:E ratio and ALA synthase 
activity in unfractionated normal human bone marrow (Section 3.6), 
suggested that myeloid cells may make a significant contribution 
to the unfractionated marrow ALA synthase activity.
Monoclonal antibody TG-1 has been identified as an lgM complement 
fixing cytotoxic antibody specific for myeloid cells from 
promyelocytes to polymorphs (Beverley et al, 1980). It has been 
used as a myeloid cell lysing agent to produce highly purified 
preparations of erythroid cells from human bone marrow (Ali et al, 
1983). The method for myeloid cell lysis has been shown to 
require incubation of the marrow cells with the monoclonal 
antibody for 30 min at 37°C.
The aim of the following series of experiments was
(1) to determine the effect of incubation at 37°C on ALA
synthase activity in unfractionated human bone marrow;
(2) to use TG-1 to lyse the myeloid cells in normal and PASA
bone marrow samples and so calculate the percentage of the
unfractionated bone marrow ALA synthase activity that is 
present in myeloid cells;
(3) to examine the reduced M:E ratio in PASA as a possible cause
of reduced ALA synthase activity in unfractionated PASA bone
marrow.
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MATERIALS AND METHODS
4.1 THE MARROW SAMPLES
Normal bone marrow was expressed from ribs resected at 
thoracotomy. Rib resections were performed on four patients with 
lung carcinoma confined to the thorax (patient 6, Section 3.3 and 
three others), on one patient with a hiatus hernia (patient 4, 
Section 3.3) and on one patient with an intrathoracic 
arteriovenous fistula (patient 5, Section 3.3). All the patients 
were haematologically normal with respect to their peripheral 
blood counts and bone marrow morphology. Marrow was obtained from 
the three patients with PASA described in Section 3.4.1.
4.2 MYELOID CELL LYSIS
TG-1 was obtained as hybridoma supernatant from Dr P Beverley, MRC 
Tumour Immunology Group, University College Hospital, London* The 
supernatant will simply be referred to as TG-1. The lysis 
technique was a modification of that described by Ali et al 
(1983). Bone marrow cells (50 x 10^) and TG-1 (2.5 ml) were mixed 
and placed on ice for 30 min. Fresh autologous plasma (2.5 ml) 
was added as a source of complement with deoxyribonucleotidase 
(DNA ase) (DN-25, Sigma) to a final concentration of 1 mg/ml. The 
sample was incubated with mixing for 30 min at 37°C. The DNA ase 
digested the DNA liberated from lysed cells and so prevented gel 
formation and clumping of the viable cells. The cells were washed 
three times in cold culture medium to remove myeloid cell debris; 
cell counts, cytospin preparations and cell differential counts 
were made.
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EXPERIMENTAL AND RESULTS
4.3 THE EFFECT OF INCUBATION AT 37°C ON ALA SYNTHASE ACTIVITY
ALA synthase activity was measured in three normal and three PASA 
bone marrow samples before and after incubation of the intact 
unfractionated marrow cells at 37°C for 30 min in fresh autologous 
plasma. Enzyme activity following incubation was expressed as a 
percentage of the activity in the non incubated sample.
Enzyme activity was shown to remain stable in marrow samples 
placed on ice for 6 hours but fell in both normal and PASA bone 
marrow with incubation at 37°C (Table 5).
The addition of reagents required to achieve myeloid cell lysis 
during incubation did not further reduce ALA-synthase activity. 
Normal bone marrow was incubated in:
(1) fresh autologous plasma +. DNA ase (1 mg/ml);
(2) culture medium (see Appendix 1)
(3) TG-1 and heat inactivated (ie complement inactivated) 
autologous serum.
As myeloid cells have been shown to contain a protease that 
inactivates ALA synthase (Aoki et al, 1978) the effect of 
myeloid cell enzymes (liberated during TG-1 lysis) on bone 
marrow ALA synthase activity was examined.
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Marrow Incubation time 
(Min)
ALA synthase activity 
(%)
Normal 30 61
Normal 30 60
Normal 30 55
PASA 30 70
PASA 30 74
PASA 30 66
NOTE: Marrow samples were incubated in fresh autologous
plasma. ALA synthase activity was expressed as a 
percentage of the non incubated unfractionated marrow 
enzyme activity
TABLE 5: The effect of incubation at 37°C on
ALA synthase activity in 
unfractionated bone marrow
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(4) marrow cells were incubated in a lysate prepared from
ultrasonicated unfractionated marrow in a 1:1 mixture of 
buffered culture medium and autologous plasma. Lysate was 
prepared to expose the non lysed cells to a concentration of 
myeloid cell enzymes threefold greater than that reached 
during TG-1 lysis.
The fall in ALA synthase activity was shown to be unaffected by 
the bone marrow lysate or by the reagents required to achieve 
myeloid cell lysis (Fig 16).
4.4 THE FALL IN ALA SYNTHASE ACTIVITY DURING INCUBATION AT
37°C IN ERYTHROID AND MYELOID BONE MARROW CELLS
Any disporportionate rate of fall in ALA synthase activity within 
either erythroid or myeloid bone marrow cells was excluded by 
examining the effect of incubation at 37°C on enzyme activity in 
unfractionated and myeloid depleted marrow samples.
ALA synthase activity in normal unfractionated marrow was 
determined after incubation at 37°C in fresh autologous plasma for 
 ^ zero 30, 50, 70 and 90 min. Myeloid cells were lysed using TG-1
f
with a 30 minute period of incubation at 37°C. ALA synthase 
activity was measured in this erythroid preparation and after a 
further 20, 40 and 60 min incubation at 37°C.
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Figure 16: The effect of TG-1 and other reagents
for myeloid cell lysis on ALA synthase 
activity in unfractionated human bone marrow
TG-1 mediated lysis of myeloid cells increased the percentage 
erythroid content of the bone marrow sample from 19 to 68%. The
fall in ALA synthase activity both in this erythroblast 
preparation and in the unfractionated marrow is shown in 
Figure 17. As the rate of fall in activity in both samples was 
parallel it was concluded that the loss had occurred from both 
myeloid and erythroid cells, without disporportionate loss from 
either.
4.5 THE CALCULATED MYELOID-DERIVED ALA SYNTHASE ACTIVITY
The calculated percentage contribution of myeloid cells to the ALA 
synthase activity in unfractionated bone marrow was determined for 
four normal and three PASA marrow samples.
Myeloid cells were lysed by the addition of TG-1 and fresh 
autologous plasma. The effect of TG-1 lysis was to increase the
mean percentage erythroid content from 17% to 64% for the normal 
samples and from 43% to 80% for the sideroblastic samples 
(residual myeloid cells < 2%). The remaining non erythroid cells 
were predominantly lymphocytes and monocytes. ALA synthase 
activity in each myeloid-free sample was expressed as a percentage 
of the activity found in the unfractionated sample, after an 
identical period of incubation in autologous plasma without TG-1: 
the difference was calculated and expressed as the percentage 
myeloid-derived ALA synthase activity.
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Figure 1 7 : The effect of incubation at 37°C on
ALA synthase activity in unfractionated 
(e—  — a) and myeloid depleted (o o)
human bone marrow
The results are shown in Table 6 . In the normal and sideroblastic 
marrows studied the mean percentage myeloid-derived ALA synthase 
activity was 49% and 48% respectively of the incubated but 
unfractionated marrow enzyme activity. As the mean M:E ratio in 
the four normal marrows was 4:1, the calculated 49% contribution 
from myeloid cells towards the enzyme activity in unfractionated 
marrow indicates that in these normal marrows individual erythroid 
cells were in general a fourfold richer source of enzyme than 
individual myeloid cells.
4.6 ALA SYNTHASE ACTIVITY IN THE CELL FREE SUPERNATANT AFTER
TG-1 LYSIS
As myeloid cells were shown to contain significant ALA synthase 
activity it was hoped to demonstrate enzyme activity in the cell 
free supernatant after TG-1 lysis of bone marrow myeloid cells.
As the supernatant contains plasma (complement), incubation medium 
for the measurement of supernatant ALA synthase activity was 
modified to accommodate the presence of plasma.
ALA synthase activity was determined in normal bone marrow as 
described and in assay incubation medium containing plasma. This 
modified incubation medium contained glycine 50 mM, CoA 1.35 mM 
GTP 5 mM, [l^C]-succinate 2 mM, STK 0.5 U, PLP 0.4 mM, sucrose 
125 mM, EDTA 5 mM, MgCl2 10 mM, Tris 25 mM buffered with KH2PO4 
12 mM and plasma 0.125 ml in a final volume of 0.5 ml. The pH was 
7.4 at 37°C. ALA synthase activity was also measured in intact
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MARROW M:E
ratio
Percentage ALA synthase activity 
TG-1 treated : myeloid cells
1 Normal 3:1 61 : 39
2 Normal 4.5:1 53 : 47
3 Normal 5:1 38 : 62
4 Normal 4:1 53 : 47
Mean 4:1 51 : 49
5 PASA 1:1 50 : 50
6 PASA 2:1 46 : 54
7 PASA 1:1 60 : 40
Mean 1.3:1 52 : 48
NOTE: ALA synthase activity was measured in unfractionated
marrow incubated at 37°C for 30 min and in fractionated 
marrow following TG-1 lysis of myeloid cells. Enzyme 
activity following TG-1 lysis was expressed as a 
percentage of the activity found in the incubated 
unfractionated marrow sample.
TABLE 6 : The myeloid-derived ALA synthase activity in 
normal and PASA bone marrow
and freeze thawed bone marrow cells, warmed to 37°C for 30 min, 
before enzyme assay in modified incubation medium.
The results are shown in Table 7. In the presence of the major 
assay reagents at normal concentration (ie glycine, CoA, GTP, STK, 
PLP and [-^C]-succinate) enzyme activity was reduced fourfold by 
the addition of plasma and sixfold by prior incubation of intact 
cells at 37°C for 30 min. ALA synthase activity was not detected 
in freeze thawed bone marrow warmed to 37°C for 30 min using 
modified incubation medium.
This inhibitory effect of plasma in the incubation mixture 
prevented the measurement of ALA synthase activity in the cell 
free supernatant after TG-1 lysis of myeloid cells. The large 
fluid volume required to produce cell lysis without clumping and 
DNA gel formation (5 ml/50 x 10^ bone marrow cells) considerably 
diluted the liberated enzyme, the activity of which was further 
lessened by the presence of plasma in the assay incubate.
The volume of fluid required for myeloid cell lysis was reduced. 
TG-1 (2.5 ml) was mixed with 50 x 10^ bone marrow cells for 30 min 
on ice. The TG-1 was removed from the cell pellet prior to the 
addition of plasma (2 ml) containing DNA ase^l mg/ml^ Cell lysis 
occurred with incubation at 37°C for 30 min, but the DNA liberated 
from the lysed cells caused gel formation and clumping of the 
viable cells. This was not prevented by increasing the 
concentration of DNA ase to 2 mg/ml. No further attempts to 
measure ALA synthase activity in the myeloid cell lysate were made.
Tissue
preparation
Incubation
medium
ALA synthase activity 
(pmol ALA/10^ erythroblast/h)
Fresh bone marrow 
cells plus 
ultrasonication Standard 780
Fresh bone marrow 
cells plus 
ultrasonication + plasma 210
Intact bone marrow 
cells incubated at 
37°C for 30 min in 
autologous plasma 
plus ultrasonication + plasma 135
Freeze thaw lysed 
bone marrow cells 
incubated at 37°C for 
30 min in autologous 
plasma plus 
ultrasonication + plasma ND
TABLE 7: The effect of adding plasma to the assay
incubation mixture on ALA synthase activity
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DISCUSSION
These experiments have established that ALA synthase activity in 
unfractionated human bone marrow is not a reliable index of 
erythroblast enzyme activity. Myeloid cells in four normal and 
three PASA bone marrow samples were shown to contribute almost 50% 
of the activity found in the unfractionated bone marrows.
All previous studies of bone marrow ALA synthase activity have 
assumed that myeloid cells make an insignificant contribution 
towards the unfractionated marrow enzyme activity and have 
expressed results solely in terms of the sample erythroblast 
content (Takaku and Nakao, 1971; Bottomley et al, 1973; Aoki et 
al, 1974, 1979; Aoki, 1980; Konopka and Hoffbrand, 1979; Fraser 
and Schacter, 1980; Tikerpae et al, 1981; Manabe et al, 1982).
This assumption may have developed from the failure of Walters et 
al (1967) to detect ALA synthase activity in normal and leukaemic 
leucocytes and no doubt is supported by the visual evidence that 
identifies erythroblasts as the most active haem forming cells in 
bone marrow. However the work of Walters et al (1967) was carried 
out prior to the development of a sensitive radiochemical assay 
and the assumption of insignificant myeloid ALA synthase activity 
appears untenable in view of:
(1) evidence that immature, leukaemic myeloid cells can
synthesise haem in significant quantities (Handler and 
Handler, 1972);
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(2) the presence of haem containing enzymes, particularly 
myeloperoxidase, to more than 5% of the dry weight of 
polymorphonuclear leucocytes (Suzuki et al, 1983);
(3) the presence of ALA synthase activity in peripheral 
blood leucocyte pellets (Brodie et al, 1977).
This work indicates that ALA synthase is present in bone marrow 
myeloid cells and that haem synthesised in myeloid cells may 
contribute to the "early labelled" bile pigment pool which 
represents some 25% of bilirubin, but is derived from sources 
other than haemoglobin catabolism (Berk et al, 1976).
A protease that inactivates the apo-form of certain pyridoxal 
enzymes has been detected in mature and immature granulocytes at 
levels similar to those found in erythroblasts. It has been 
proposed that this protease is a regulator of erythroblast ALA 
synthase (Aoki, 1978). The presence of ALA synthase activity in 
bone marrow myeloid cells may now suggest a similar function for 
the protease in these cells.
Differences in the M:E ratio and myeloid-derived ALA synthase 
activity were not shown to cause the reduced ALA synthase activity 
found in unfractionated PASA bone marrow samples. Myeloid cell 
lysis produced a similar percentage reduction in enzyme activity 
in normal and PASA marrow and demonstrated low enzyme activity in 
the residual sideroblasts. If insignificant myeloid ALA synthase 
activity had been found in PASA then normal erythroid activity 
plus reduced myeloid activity might have combined to produce 
reduced whole marrow ALA synthase activity.
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In the three PASA cases studied myeloid cell ALA synthase activity 
was not reduced. From the mean unfractionated marrow enzyme 
activity of 400 pmol ALA/h in PASA (Section 3.7), the mean 
myeloid-derived activity (approximately 50% of the total) may be 
calculated to be 200 pmol/h. Correction for a mean M:E ratio of 
1.3:1 in the three PASA bone marrow samples provides a calculated 
myeloid-derived ALA synthase activity in PASA of approximately 
150 pmol ALA/10^ bone marrow myeloid cells/h. Examination of the 
M:E ratio and ALA synthase activity in 11 normal unfractionated 
bone marrow samples (Section 3.6) indicates that in all cases it 
would be unlikely and in most cases impossible, for the myeloid 
cell enzyme activity to exceed this value. As only three cases of 
PASA were studied these results should be considered to be of a 
preliminary nature. If substantiated however they would identify 
reduced mitochondrial ALA synthase activity in PASA to be evident 
only in the erythroid fraction of bone marrow, which in turn is 
the only cell to show mitochondrial iron loading (Larizza and 
Orlandi, 1964). This would contrast with the study of Aoki (1980) 
who demonstrated reduced activity of other myeloid mitochondrial 
enzymes, cytochrome oxidase, serine protease and oligomycin- 
sensitive ATP ase in peripheral blood polymorphs in PASA. However 
unlike the three cases studied here, in which peripheral white 
cell counts and differentials were normal, the majority of cases 
studied by Aoki (1980) had low circulating white cell counts.
ALA synthase activity was shown to fall during incubation of bone 
marrow cells at 37°C for 30 min. This period of incubation was
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required to allow TG-1 mediated lysis of myeloid cells. The fal-1 
in activity was not related to the presence of reagents required 
for myeloid cell lysis nor was it prevented by the presence of 
glycine in the culture medium. The activity fell both in PASA and 
normal bone marrow samples and was shown to occur without a 
disproportionate loss in either myeloid or erythroid cells. The 
cause of this fall in activity is not clear and may warrant 
further examination in future studies. In particular the effect 
of proteolytic inhibitors should be determined. As the protease 
for ALA synthase (Aoki, 1978) is thought to be a serine protease, 
the effect of the serine protease inhibitor diisopropyl 
fluorophosphate should be examined. The effects of pyridoxine, 
pyridoxal phosphate and other pyridoxine metabolites require to be 
investigated as it has been found that pyridoxal phosphate 
protects against an irreversible temperature dependent 
inactivation of hepatic ALA synthase activity in mitochondrial 
matrix fraction (Beattie et al, 1985). The pattern of 
inactivation in the mitochondrial matrix was similar to that shown 
in Figure 17 with approximately 50% inactivation after 30 min at 
37°C. This temperature dependent loss of activity stresses the 
importance of maintaining the bone marrow sample at 4°C during 
procedures such as centrifugation and ultrasonication which might 
cause an increase in sample temperature with consequent 
inactivation of ALA synthase.
The results reported in this chapter indicate that in the study of 
haem biosynthetic enzymes in bone marrow the contribution of
89
myeloid and erythroid cells should be clearly and separately 
defined using suitably sensitive enzyme assays. Even when this is 
done it is important to recognise the likely relationship between 
enzyme activity and cell age. In relation to ALA synthase
activity this would apply both to myeloid and erythroid cells.
Polymorphonuclear leucocytes in blood are terminally 
differentiated granulocytes, in transit to the tissues. They are 
chiefly concerned with bacterial phagocytosis and are equipped 
with very few mitochondria and a limited capacity for protein 
synthesis (Cawley and Hayhoe, 1973). In contrast immature 
granulocytes are rich in mitochondria and are actively engaged in
protein synthesis. It is then presumably the immature bone marrow
myeloid cells that provide most of the myeloid-derived ALA 
synthase activity. The effect of myeloid differentiation on ALA 
synthase activity would be difficult to study using "in vivo" bone 
marrow myeloid cells as no method has been described for isolating 
and age matching developing myeloid cells in human bone marrow. 
However, the study of acute myeloid leukaemia cell lines (HL-60, 
KG-1) has identified maximal synthesis of haem containing 
myeloperoxidase in promyelocytes with negligible synthesis in 
mature myeloid cells (Koeffler et al, 1985). The same cell lines 
may provide information on ALA synthase activity during myeloid 
cell differentiation.
The relationship between ALA synthase activity and human 
erythroblast differentiation in normal and pathological 
erythroblasts has never been examined before and is the subject of 
Chapter 5.
This discussion has provided possible ideas for future studies.
It has also indicated the need to reassess the value of measuring 
ALA synthase activity in unfractionated bone marrow and the 
conclusions drawn from previous studies which have used this as a 
measure of erythroblast enzyme activity. It would seem as if 
unfractionated bone marrow ALA synthase activity is at best a 
crude indicator of erythroblast activity, insensitive to the 
contribution made by myeloid cells and to the differences in 
enzyme activity that may occur in relation to cell differentiation.
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CHAPTER 5
5-AMINOLAEVULINIC ACID SYNTHASE 
ACTIVITY IN HUMAN ERYTHROBLASTS
5. 5-AMINOLAEVULINIC ACID SYNTHASE 
ACTIVITY IN HUMAN ERYTHROBLASTS
The aim of the work described in this chapter was to provide a 
direct measure of ALA synthase activity in human erythroblasts and 
examine the effect of differentiation on enzyme activity in normal 
and pathological states.
Within mature red cells the specific complexing of haem with 
glob in provides the cell with its unique oxygen carrying 
properties. In the marrow however there is evidence that haem 
synthesis proceeds globin synthesis (Glass et al, 1975a, Forget et 
al, 1976) and that haem synthesised rapidly at the outset of 
differentiation may be required not for haemoglobin production but 
for the co-ordinate regulation of erythroblast metabolism and 
differentiation (Glass et al, 1975a). The activities of the 
various haem biosynthetic enzymes during human erythroblast 
differentiation require to be defined as the extent to which 
intracellular free haem may be involved in the control of globin 
synthesis, iron metabolism, haem metabolism and differentiation 
will depend on the ability of erythroid cells to synthesise haem 
during their development.
5.1 THE ROLE OF HAEM IN GLOBIN PRODUCTION IN ERYTHROID CELLS
In reticulocytes haem has been shown to exert translational 
control on globin synthesis through a haem controlled repressor
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(HCR) of globin m RNA translation (Karibian and London, 1965;
Gross, 1980).
Within developing nucleated erythroid cells however globin gene 
expression appears to be regulated mainly at the transcriptional 
level (Harrison, 1984). In the FEL cell system no HCR activity 
was found in a haem deficient mutant (Rutherford and Weatherall, 
1979) and it has been suggested that haem may increase globin 
m RNA either by acting directly on the globin genes or by 
increasing the proportion of cells that accumulate globin 
messenger (Ross and Saunter, 1976; Rutherford and Weatherall,
1979).
5.2 THE ROLE OF HAEM IN REGULATING IRON UPTAKE BY ERYTHROID
CELLS
Reticulocyte iron uptake is inhibited by haem (Ponka and Neuwirt, 
1969) and increased by inhibitors of haem synthesis such as 
isoniazid (INH), an antipyridoxal agent (Bottomley, 1982) and 
succinylacetone (Ponka et al, 1982), an inhibitor of ALA 
dehydratase (Tschudy et al, 1981; Sassa and Kappas, 1983). It has 
been proposed that an intracellular free haem pool (Neuwirt et al, 
1972) may regulate erythroid iron uptake by controlling the 
release of iron from transferrin (Ponka et al, 1974) and that haem 
may also alter the number of transferrin receptors on developing 
erythroid cells (Pelicci et al, 1982). The presence of 
hypochromic cells in the blood in PASA and reduced levels of ALA
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synthase activity in PASA bone marrow samples have led to the 
hypothesis that a primary deficiency of haem synthesis in PASA 
allows increased erythroblast iron uptake and mitochondrial iron 
loading (Ponka and Neuwirt, 1974).
Not all studies support this hypothesis or the belief that haem 
regulates erythroblast iron uptake. Abnormal localisation of 
intracellular iron and reduced erythroblast iron incorporation 
into haem have been documented in PASA, but found to occur without 
any overall increase in the iron uptake of individual cells (May 
et al, 1982a). INH has not been found to increase human 
erythroblast iron uptake (May et al, 1982b) and may itself 
interfere with iron uptake studies, as the hydrazone formed 
between pyridoxal and INH is a powerful iron chelator (Ponka et 
al, 1979). Increased reticulocyte iron uptake in the presence of 
succinylacetone is not associated with chelator formation but does 
not in itself provide sufficient evidence to indicate that similar 
results might be expected with erythroblasts.
5.3 EFFECT OF HAEM ON ERYTHROID DIFFERENTIATION
In addition to there being evidence supporting haem as a major 
coordinator of erythroblast metabolism, it has also been suggested 
that haem may regulate erythroblast differentiation. Two major 
factors have been established in the control of erythropoiesis. 
Erythropoietin is primarily effective at the terminal stages of 
differentiation, whereas burst promoting activity (BPA) appears to
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enhance the more primitive erythroid precursors (Lipton and 
Nathan, 1983). Of the other factors T-cell macrophage interaction 
may sensitise erythroid progenitors to erythropoietin (Kurland et 
al, 1980; Lipton et al, 1980), T suppressor cells may exercise 
negative regulation (Lipton and Nathan, 1983), thyroxine and 
growth hormone are thought to interact with erythropoietin and 
58-H steroid metabolites appear to directly affect erythroid 
precursors by an erythropoietin independent mechanism (Necheles 
and Rai, 1969; Gordon et al, 1970; Urabe et al, 1979). In FEL 
cells DMSO can stimulate differentiation and may do so before the 
cells have developed the ability to synthesise haem (Friend et al, 
1971; Sassa, 1976). This suggests that haem synthesis is 
stimulated after differentiation has been triggered. However as 
the growth and differentiation of FEL cells is completely 
inhibited by succinylacetone (Tschudy et al, 1980) it would seem 
as if differentiation and haem synthesis in FEL cells are 
inextricably linked.
Evidence in support of haem as a regulator of erythroid 
differentiation has come from increased erythroid colony growth 
following the "in vivo" injection of haemin to mice (Monette et 
al, 1984) and the "in vitro" addition of haemin to murine (Monette 
and Holden, 1982; Ibrahim et al, 1982) and human (Lu and 
Broxmeyer, 1983) bone marrow cultures. The enhancement of murine 
BFU-E following the "in vivo" injection of haemin was compared 
with its failure to stimulate CFU-S (pluripotent cells), (Monette 
et al, 1984) and the enhancement of human BFU-E and CFU-GEMM, by
95
"in vitro" addition of haemin was compared with its failure to 
stimulate CFU-GM (Lu and Broxmeyer, 1983). These results argue 
strongly in favour of a specificity of haemin action localised to 
the most primitive erythroid progenitors.
5.4 THE ROLE OF HAEM IN THE REGULATION OF ERYTHROID HAEM
BIOSYNTHESIS
It is well established that ALA synthase is rate limiting for 
hepatic haem biosynthesis and subject to negative feedback control 
by haem (Granick and Urata, 1963). The role of the enzyme in 
erythroid haem biosynthesis is however unclear. With 
reticulocytes it has been demonstrated that haem inhibits haem 
synthesis (Karibian and London, 1965; Neuwirt et al, 1974) and ALA 
synthase activity, in intact cells, in isolated mitochondria 
(Ibrahim et al, 1978) and in purified enzyme suspensions (Aoki et 
al, 1971), but does so however at concentrations 100 fold greater 
than that required to inhibit liver ALA synthase (Ibrahim et al, 
1978). The hypothesis relating iron uptake and haem synthesis has 
further been extended to suggest that a reciprocal arrangement 
exists whereby haem may regulate iron uptake but that reduced 
reticulocyte iron uptake may in turn also reduce haem synthesis 
(Neuwirt et al, 1974). However as the inhibition of haem 
synthesis by the addition of haem to intact reticulocytes can be 
demonstrated in the absence of transferrin iron (Ibrahim et al,
1978) it would seem as if this hypothesis is unproven and perhaps 
unlikely.
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With erythroblasts the effect of haem on haem synthesis has not 
been established and has been limited by the inability to obtain 
suitable preparations of differentiating mammalian erythroid 
cells. It would seem likely however as if two factors are 
involved in regulating erythroblast haem biosynthesis; firstly, 
the level of erythroid differentiation and secondly, short term 
regulators that operate to finely tune haem synthesis in cells 
actively synthesising haem (Elder, 1981). It is always difficult 
with erythroid cells to analyse these factors separately and no 
previous studies have been able to clearly dissociate the primary 
effect that agents such as erythropoietin (Nakao et al, 1968; 
Bottomley and Smithee, 1969) and 58-H steroid metabolites (Gordon 
et al, 1970; Urabe et al, 1979) have on haem synthesis and ALA 
synthase, as distinct from effects that occur secondary to their 
promoting erythroid differentiation (Urabe et al, 1979).
5.4.1 The effect of erythroblast differentiation on haem 
synthesis
In the absence of access to purified human erythroblasts, the 
relationship between erythroid differentiation and haem synthesis 
has been studied in different erythroid systems with different 
results. In chick blastoderm the development of ALA synthase 
activity was identified as the final stage in the initiation of 
haemoglobin synthesis during erythroid differentiation (Levere and 
Granick, 1965). However in foetal mouse liver (Freshney and Paul, 
1971), FEL cells (Ebert and Ikawa, 1974; Sassa, 1976) and murine 
bone marrow cultures (Ibrahim et al, 1982) ALA synthase was shown
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not to be limiting for haemoglobin production, as enzyme activity 
was evident and maximal prior to haemoglobin formation. The 
demonstration of sequential development of the enzymes of haem 
synthesis in foetal mouse liver (Freshney and Paul, 1971) and FEL 
cells (Sassa, 1976; Rutherford et al, 1979) led to the hypothesis 
that haem synthesis in developing erythroid cells was limited by 
the late induction of ferrochelatase activity. However, in 
contrast, Beaumont et al (1984) demonstrated synchronous rather 
than sequential, development of ALA synthase and ferrochelatase 
activity in FEL cells and suggested that haemoglobin formation may 
be limited by the availability of ferrous iron to protoporphyrin 
rather than the late appearance of ferrochelatase activity.
5.4.2 The effect of intracellular regulators of erythroblast 
haem synthesis
Regulators of erythroid haem biosynthesis have also been studied 
in many different erythroid systems. Haem has been shown to 
inhibit the synthesis of ALA synthase in cultured embryonic chick 
liver cells (Sinclair and Granick, 1975) but not in foetal rat 
liver cells (Woods, 1974). In foetal mouse liver erythroblasts, 
haem inhibits haem synthesis at several sites, with a greater 
effect on ALA dehydratase than on ALA synthase (Malik et al,
1979). The addition of haem to FEL cells promotes differentiation 
(Ross and Sautner, 1976) and has been shown by direct measurement 
to induce ALA dehydratase and URO-synthase activity and by 
indirect measurement ALA synthase and ferrochelatase (Granick and 
Sassa, 1978). In view of its inhibitory effect on reticulocyte
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ALA synthase (Aoki et al, 1971), it has been suggested that haem 
may have contradictory effects on two types of erythroid cell; in 
undifferentiated erythroid cells haem may induce ALA synthase 
(Granick and Sassa, 1978; Sassa and Kappas, 1980; Elder, 1981; 
Ibrahim et al, 1983) whereas in differentiated cells it may 
inhibit enzyme activity. Direct measurement of ALA synthase 
activity in DMSO stimulated FEL cells has however shown that a 
reduction in haem synthesis effected by succinylacetone produced a 
sixfold increase in ALA synthase activity after four days in 
culture and that this effect was reversed by the addition of haem 
(Beaumont et al, 1984). This then suggests that haem exerts 
negative, rather than positive, control over the induction of ALA 
synthase activity in early erythroid precursors and that haem 
present in the nucleus of FEL cells at day 3 of culture with DMSO 
(Lo et al, 1981) may be there to limit activation of the ALA 
synthase gene.
It has been suggested that ALA synthase activity in developing 
erythroblasts may be regulated by the activity of a protease 
specific for pyridoxal enzymes (Aoki, 1978, 1980) and that low 
levels of enzyme activity in sideroblastic anaemia may be effected 
either by reduced enzyme production or by increased sensitivity of 
the apo enzyme to the protease (Aoki, 1980, Manabe et al, 1982).
These results indicate that the mechanisms regulating erythroblast 
haem biosynthesis and ALA synthase activity are tissue specific, 
species specific and differentiation status dependent. The
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relative importance of short term regulators in controlling 
erythroblast haem synthesis is uncertain. Haem proteins in liver 
cells turn over rapidly and so require the described system 
(Chapter 1) by which haem controls short term fluctuations in the 
rate of haem synthesis by its effect on ALA synthase activity. In 
contrast the long half life of haemoglobin has been argued to 
mitigate against the need for a similar system in erythroblasts, 
in which the level of differentiation has been proposed as the 
major determinant of ALA synthase activity and haem synthesis 
(Tait, 1978; Elder, 1981).
The study of haem synthesis during human erythroblast 
differentiation demands attention. As has been discussed 
erythroblast haem synthesis may not merely represent a process 
designed to provide haem for circulating red cells, but may also 
represent a process of central importance to erythroblast 
metabolism and normoblastic differentiation. The work in this 
chapter describes the effect of normal and pathological 
erythroblast differentiation on ALA synthase activity.
Measurement of enzyme activity in age matched erythroblasts has
detected reduced ALA synthase activity in sideroblastic, CDA and
I a .thalassfemic erythroblasts. These results have been used to 
examine the proposed role of reduced ALA synthase activity in the 
development of mitochondrial iron loading and in the pathogenesis 
of PASA.
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EXPERIMENTAL AND RESULTS
5.5 THE PATIENTS STUDIED
Bone marrow was obtained by posterior iliac crest aspiration from 
three patients with normoblastic erythroid hyperplasia, three 
patients with PASA, two patients with thalassaemia intermedia and 
two patients with CDA. Haematological information on the ten 
patients is shown in Table 8. All patients had erythroid 
hyperplasia and have already been described (Section 3.4).
Electron microscopy was performed to examine the ultrastructural 
appearance of the CDA erythroblasts to determine the degree and 
nature of any intracellular iron accumulation.
5.5.1 Patients with normoblastic erythroid hyperplasia 
It had been hoped that marrow would be obtained from patients with 
brisk peripheral red cell haemolysis. However no such patients 
were available at the time of study. Marrow was aspirated on the 
fifth day of haematinic replacement from patients with severe 
megaloblastic anaemia. In the three cases (initially described in 
Section 3.4) the marrow (at^day^5 showed^normoblastic erythroid 
hyperplasia. The patients had been treated with hydroxocobalamin 
1000 ug fjimy'days 1-3, ferrous sulphate 200 mg tds days 1-5 and 
folic acid 5 mg tds days 1-5. Ferrous sulphate was given to 
prevent the fall in serum iron to the iron deficient levels 
associated with the introduction of appropriate replacement
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therapy in megaloblastic anaemia and which is caused by the early 
change from ineffective megaloblastic to effective normoblastic 
erythropoiesis (Chanarin, 1979).
It was noted that ALA synthase activity in unfractionated 
megaloblastic marrow (see Table 3) was higher than that found in 
unfractionated normoblastic marrow (Table 8) aspirated from the 
same patients after five days of haematinic replacement.
5.6 ERYTHROBLAST FRACTIONATION
The bone marrow myeloid cells were lysed by TG-1 plus complement.
The mean percentage erythroid cells in the 10 marrows after TG-1
lysis was 86% (range 75-96). Percoll equilibrium density 
centrifugation (Ali et al, 1982, 1983; May et al, 1982) was used 
to fractionate the erythroblasts at different stages of 
development. The cells were removed from four different density 
levels from each percoll density gradient.
5.6.1 Percoll gradients
54 ml percoll was made isotonic by the addition of 6 ml 8 g/dl 
sodium chloride and was prepared to a specific density of 
1.083 g/1 by the further addition of 32 ml culture medium 
(Appendix 1). The density gradients were prepared in 10 ml 
capacity capped polycarbonate centrifugation tubes, spun with the 
brake off in an MSE 25 angle-head rotor for 45 min at 20,000 g and 
4°C.
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Bone marrow erythroblasts were washed three times in cold culture 
medium after TG-1 myeloid cell lysis and were suspended in heat 
inactivated filtered foetal calf serum to a concentration of 
50 x 10^/ml. 1 ml of this erythroblast suspension was carefully
layered onto each preformed density gradient maintained at 4°C. 
Gradients were then spun in a refrigerated centrifuge at 4°C for 
15 min at 1400 g. Erythroblasts were removed from four preset 
density fractions, identified by percoll density marker beads 
added to a blank percoll gradient before centrifugation at 1400 g 
(Fig 18). Erythroblasts were washed three times in cold culture 
medium at 4°C. Cell counts and cytospin preparations were made 
from each percoll fraction. Erythroblast pellets in capped 
sonication tubes were snap frozen with CO2 ice and stored at 
-70°C. On the day of assay, incubation medium was freshly 
prepared and 1.5 ml added to the cell pellet. Sonication and 
measurement of ALA synthase activity was carried out as described 
(Chapter 2) with all samples being assayed in duplicate.
5.6.2 The erythroblasts in percoll fractions 
Cytospin preparations of the erythroblasts in the four percoll 
fractions were examined by light microscopy. Erythroblast 
maturity in the percoll fractions was assessed by differential 
counting of 400 cells. Each fraction was scored for its content 
of pro and basophilic early erythroblasts (Ej), polychromatic 
intermediate erythroblasts (E2) and orthochromatic late 
erythroblasts (E3).
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Marker beads indicate density levels after centrifugat 
at 1400 gav for 15 min.
Note: colour of bead
orange 
blue/green 
red
blue/purple 
yellow 
green 
pink
density (g/ml)
1.034 
1.048 
1.062 
1.076 
1.087 
1.100 
1.118
Figure 18: A percoll density gradient
Separation on the basis of density was found to provide successful 
separation of erythroblasts according to their state of 
differentiation. From microscopic examination of cells at 
different depths on a spun gradient, four percoll density 
fractions were selected as providing the most satisfactory 
separation of Ej cells from E2 cells from E3 cells. Each fraction 
corresponded to the following density steps (g/ml): 
fraction 1: 1.062 - 1.070
fraction 2: 1.070 - 1.080
fraction 3: 1.080 - 1.100
fraction 4: 1.100 - 1.118
As has been shown with velocity centrifugation (Denton and 
Arnstein, 1973) the most effective erythroblast separation was 
obtained from marrows that showed pronounced erythroid 
hyperplasia. Normal marrow lacking erythroid hyperplasia was 
found to contain few pro and early basophilic erythroblasts, such 
that the percoll fractions containing these immature erythroid 
cells were also found to contain large numbers of contaminating 
lymphocytes and monocytes.
Within the equivalent fractions from the different marrows ' 
examined, the erythroblasts were found to be at a comparabie level 
of maturity so permitting comparison of ALA synthase activity 
between age matched erythroblasts from normal and pathological 
marrow samples. The mean erythroblast differential counts in the 
percoll fractions from the three normoblastic, three PASA, two CDA 
and two thalassaemia marrows were similar and are shown in 
Table 9. Pro and early basophilic (Ej) erythroblasts were most
n
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NORMOBLASTIC
NOTE:
TABLE
Sample E1 e2 e3
% % %
Percoll 1 41 42 17
Percoll 2 19 69 12
Percoll 3 2 65 33
Percoll 4 26 74
SIDEROBLASTIC
Percoll 1 35 50 15
Percoll 2 24 56 20
Percoll 3 8 68 24
Percoll 4
CDA
39 61
Percoll 1 45 37 18
Percoll 2 27 48 25
Percoll 3 4 55 41
percoll 4 39 61
THALAS SAEMIA
Percoll 1 40 40 20
Percoll 2 27 48 25
Percoll 3 4 55 41
Percoll 4 39 61
The erythroblast differential cell 
counts were made from the 
examination of 400 cells
9_: Mean erythroblast differential counts from
the percoll gradients
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prominent in fraction 1. These immature cells were present to a 
lesser extent in fraction 2, but were outnumbered by intermediate 
(E2) polychromatic erythroblasts. Percoll fraction 3 contained 
more intermediate than late (E3) erythroblasts with the reverse 
situation being the case in fraction 4. (see photographic plates)
5.7 ALA SYNTHASE ACTIVITY DURING NORMOBLASTIC ERYTHROPOIESIS
Maximum ALA synthase activity was found in the erythroblasts of 
percoll fractions 1 and 2. The activity in these fractions was 
approximately four times greater than that found in the late 
erythroblasts of percoll fraction 4 (Fig 19).
This result indicates that the induction of ALA synthase activity 
occurs early during normoblastic erythroid differentiation. ALA 
synthase activity was found to be high in pro and early 
erythroblasts (percoll fraction 1) and to possibly slightly 
increase as these cells differentiate towards intermediate 
erythroblasts (percoll fraction 2). Further differentiation 
towards the intermediate and late erythroblasts of percoll 
fractions 3 and 4 was associated with a sharp fall in ALA synthase 
activity.
Bone marrow reticulocytes were present in large numbers in percoll 
fraction 4 and outnumbered E3 cells by a factor of > 10:1. Low 
levels of ALA synthase activity in this fraction relative to the 
activity found in reticulocyte free fractions 1 and 2, indicates
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Normoblastic Marrow500n
400-
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1 2 3 4
Percoll fractions
Note: Each point represents the mean of two observations.
Figure 19:
that the activity present in reticulocytes is extremely low, 
perhaps several hundred times lower than that of cells. The 
magnitude of this reduction would appear to indicate the 
considerable risk involved in extrapolating results from the study 
of haem synthesis in reticulocytes to that in erythroblasts.
It is clear from morphological examination that considerable ALA 
synthase activity is present in the cells of fraction 1 before the 
appearance of significant amounts of cytoplasmic haemoglobin.
Bone marrow red cells were recovered in large numbers together 
with the late erythroblasts in percoll fraction 4. As ALA 
synthase activity was low in this fraction, enzyme activity was 
measured by mixing cells from fractions 1 and 4, to exclude any 
inhibition of ALA synthase activity by homogenised red cells 
present during assay incubation. No evidence of inhibition was 
found and this indicated that the low levels of enzyme activity in 
percoll fraction 4 were a true measure of low ALA synthase 
activity in late erythroblasts.
5.8 ALA SYNTHASE ACTIVITY DURING SIDEROBLASTIC ERYTHROPOIESIS
ALA synthase activity during sideroblastic erythropoiesis did not 
show the same pattern of activity evident during normoblastic cell 
development (Fig 20). Rapid induction of ALA synthase activity 
was not seen in the early erythroblasts in PASA and mean enzyme 
activity was three-fourfoid lower in percoll fractions 1 and 2 in 
sideroblastic than in normoblastic marrows (p < 0.5). ALA
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Figure 20:
synthase activity in the more mature sideroblasts of percoll 
fractions 3 and 4 was similar to that in normoblasts of equivalent 
maturity.
5.8.1 Intracellular iron accumulation during sideroblastic 
erythropoiesis
Cytochemical staining for iron was performed on cells in the 
percoll fractions obtained from the sideroblastic marrow samples. 
Pathological iron loading was seen at all stages of erythroid 
development. This was most apparent in the erythroblasts of 
percoll fractions 3 and 4. E£ and E3 cells showed the 
characteristic ring sideroblast defect, indicative of 
mitochondrial iron loading. Ej cells showed iron deposits which 
were smaller and less numerous than those seen in the more mature 
erythroblasts but which appeared either to be in the cytoplasm or 
on/in the cell nucleus.
5.9 ERYTHROBLAST ALA SYNTHASE ACTIVITY IN THALAS SAEMIA AND CPA
The erythroblasts from patient 7 with thalassaemia intermedia 
contained extremely high levels of ALA synthase activity (Fig 
21). Activity was maximal in percoll fraction 2 and remained high 
during differentiation and in the late erythroblasts (E3) of 
percoll fraction 4.
ALA synthase activity during erythroid differentiation in the 
other patient with thalassaemia intermedia (patient 8) and in both 
patients with CDA (Fig 22) was similar to that found in PASA.
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Enzyme activity in percoll fractions 1 and 2 did not show the high 
activity evident in normoblastic cells of equivalent maturity 
(p < 0.5) but was found to be similar in fractions 3 and 4 to that 
of normoblastic fractions 3 and 4.
5.9.1 Erythroblast iron loading in CPA and thalassaemia 
As reported in Sections 3.4.3/4 light microscopy identified 8% and 
2% ring sideroblasts with 20% and 5% pathological sideroblasts in 
CDA patients 9 and 10 and 2% and 5% ring sideroblasts with 10% and 
20% pathological sideroblasts in thalassaemia patients 7 and 8.
Electron microscopy identified mitochondrial iron loading in 47% 
and 31% respectively of the erythroblasts of CDA patients 9 and 10.
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PHOTOGRAPHIC PLATES
Plate 1
Ring sideroblasts (x 1000)
PERCOLL EQUILIBRIUM DENSITY CENTRIFUGATION OF 
HUMAN BONE MARROW ERYTHROBLASTS
Erythroblast differentials
Differential counting of erythroblasts is a subjective procedure 
liable to interobserver variation. The differential counts on the 
cells in the 4 percoll fractions (reported in table 10) were made 
on 400 cells by two independent observers who scored the stage of 
erythroid development by the following criteria for cell 
recognition.
Proerythroblasts: large immature cells with chromatin
condensation (and hence erythroid origin).
Early erythroblasts: large immature cells with basophilic
cytoplasm and erythroid nuclei.
Intermediate erythroblasts; smaller cells with smaller non 
pyknotic nuclei and polychromatic cytoplasm.
Late erythroblasts: small well haemoglobinised cells with a small
pyknotic nucleus.
Within each of the three defined erythroblast groups (Ej, E2, E3) 
different stages of differentiation were seen. This was most 
apparent with E£ cells. From the erythroblast appearances as 
shown in Plates 5-15 it may be seen that the intermediate 
erythroblasts of percoll fraction 2 were in general less mature 
than the intermediate erythroblasts of percoll fraction 3.
PERCOLL FRACTIONS
Fraction 1 (plates 2-4): proerythroblasts and early
erythroblasts were prominent in this fraction which also contained 
equal numbers of intermediate erythroblasts.
Fraction 2 (plates 5-8): intermediate erythroblasts represented
the majority of cells present. E^ cells at 20-30% were less 
prominent than in percoll fraction 1.
Fraction 3 (plates 9-14): intermediate erythroblasts were again
most numerous. Early erythroblasts were seen infrequently, with 
well haemoglobinised late erythroblasts at 30-40%.
Fraction 4 (plates 15-18): this fraction contained predominantly
mature red blood cells. Erythroblasts that were present were for 
the most part at the late stage of development.
Plate 2
Proerythroblasts (x 1000'
Plate 3
Proerythroblasts (x 1200)
Percoll fraction 1
Plate 4
Early erythroblasts (x 1000)
Percoll fraction 2
Plate 3
Intermediate erythroblasts (x 1000)
Plate 6
Early and intermediate erythroblasts (x 1000)
(late erythroblast at 6 o'clock)
Percoll fraction 2
Plate 7
Early and intermediate erythroblasts (x 1000)
Plate 8
*
0
Early and intermediate erythroblasts (x 1000)
(late erythroblasts at 2 o'clock and 8 o'clock)
Percoll fraction 3
Plate 9
m
%
»
Intermediate erythroblasts
Plate 10
*
m
#
Intermediate erythroblasts
(two late erythroblasts present)
Percoll fraction 3
Plate 11
Jfit
*
m M ' *
Intermediate erythroblasts x 1000
Plate 12
•  * 
• * * •
Intermediate and late erythroblasts (x 1000)
Percoll fraction 3 
Plate 13
•:
Intermediate and late erythroblasts 
Plate 14
•  »
$
( •
#
Intermediate and late erythroblasts
Percoll fraction 4
Plate 13
•  • •  c
m  _•/-* _ 0
late and intermediate erythroblasts 
with large numbers of RBCs
Plate 16 
#
#  •
late and intermediate erythroblasts 
with large numbers of RBCs
Percoll fraction 4
Plate 17
• •
late erythroblasts (plus 2 intermediate) (x 600)
Plate 18
• *
m
late erythroblasts (1 intermediate) (x 1000)
Percoll fractions 1 - 4
PASA erythroblasts (patient 6; table 8)
Percoll fractions 1 and 2
Plate 19
Percoll fraction 1
Plate 20
(x 1000)
Percoll fraction 2 (x 1000)
Percoll fractions 3 and 4
Plate 21
* •
Percoll fraction 3 x 1000
Plate 22
e #
m
Percoll fraction 4 (x 600)
DISCUSSION
This work has provided three points of considerable interest. 
Firstly, it has shown that haem synthesis and in particular ALA 
synthase may be examined in differentiating "in vivo" human 
erythroblasts so that information on human erythroid haem 
synthesis need no longer be derived by inference from the study of 
foetal mammalian erythroid systems or "in vitro" erythroid cell 
culture systems. Secondly, it has clearly and directly confirmed 
the suspicions arising from reported studies using unfractionated 
human bone marrow, that erythroblast ALA synthase activity is 
reduced in PASA. Lastly, this work has for the first time 
directly measured human erythr'oblast ALA synthase activity and has 
described conditions in which erythroblast ALA synthase activity 
was found to be reduced to levels similar to those found in PASA, 
but in which ring sideroblasts were not prominent on light 
microscopy.
Monoclonal antibody TG-1 and percoll equilibrium density 
centrifugation were combined to achieve physical separation of 
erythroid cells at different stages of development from one - 
another and from the non erythroid cells also present in the 
original marrow samples. The development of such a system is an 
essential prerequisite to any advance in understanding the complex 
biochemical and molecular events of human erythroid 
differentiation.
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Various methods have been used previously to fractionate 
developing .erythroblasts. Bone marrow erythroblasts may be 
synchronised in animals by injections of actinomycin D and 
harvested at intervals thereafter (Konijn et al, 1979). Physical 
separation techniques of velocity (Denton and Amstein, 1973) and 
density (Borsook et al, 1969) centrifugation have been used 
successfully to fractionate rabbit and mouse (Glass et al, 1975b) 
erythroblasts, but require either treatment of the animals with 
phenylhydrazine, splenectomy or lengthy and repeated 
centrifugations at room temperature. Human erythroblast 
fractionation using TG-1 and percoll centrifugation was first 
described by Ali et al (1983). It was modified by selecting 
slightly different percoll fractions from those initially used 
(Ali et al, 1983) and was adopted for use. The advantage of using 
this method was that the centrifugation step was short and 
refrigerated and that high percentage cell recoveries (Ali et al, 
1983) permitted its use with small cell numbers.
The density of developing erythroblasts is determined mainly by 
the nuclear size and haemoglobin concentration (Borsook et al, 
1969). As these characteristics do not change synchronously 'in 
every cell some erythroblast heterogeneity in the percoll 
fractions was unavoidable. However the four fractions chosen 
produced reproducible erythroblast fractionation and have provided 
clear information on the effects of normal and abnormal 
differentiation on ALA synthase activity. It is of course 
possible that improved fractionation could be obtained by
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increasing the number of percoll fractions sampled or perhaps by 
combining myeloid cells lysis with refrigerated velocity 
centrifugation. Such steps would be those most immediately 
available for assessment if future experiments, perhaps regarding 
the molecular analysis of human erythropoiesis, demanded more 
complete erythroblast fractionation.
Normoblastic erythroid differentiation was associated with the 
early induction of high ALA synthase activity in pro and 
basophilic erythroblasts which fell rapidly with differentiation 
towards late erythroblasts. As haemoglobin cannot be demonstrated 
in proerythroblasts (Undritz, 1973); as its production only starts 
after the basophilic erythroblast (Hammarsten et al, 1953; Forget 
et al, 1976); and as the rapid phase of haemoglobin production 
occurs only after the polychromatic phase of erythroblast 
differentiation (Denton et al, 1975) it would appear as if ALA 
synthase activity does not limit human erythroblast haemoglobin 
production. This suggests either that erythroblast haem synthesis 
precedes globin synthesis (Forget,et al, 1976) and/or that, as 
with FEL cells (Sassa, 1976) and mouse foetal hepatic 
erythroblasts (Freshney and Paul, 1971) and in contrast to liver 
cells (Granick and Urata, 1963), ALA synthase activity does not 
limit human erythroblast haem synthesis. Although haem and globin 
synthesis may indeed occur asynchronously they are sufficiently 
closely matched to be considered as simultaneous (Paul, 1978).
This would suggest that the latter proposal is more likely.
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Results from studies with FEL cells are contradictory as to 
whether haem synthesis is limited by the sequential development of 
haem enzyme activity and late induction of ferrochelatase activity 
(Sassa, 1976) or by the availability of ferrous iron to 
protoporphyrin (Beaumont et al, 1984). The direction for future 
experiments is to determine the temporal relationship between ALA 
synthase activity, ferrochelatase activity and haem synthesis in 
differentiating human erythroblasts.
The present work has directly identified reduced ALA synthase 
activity in immature PASA erythroblasts and supports the 
hypothesis originally developed from indirect evidence that haem 
synthesis is deficient in PASA. The presence of microcytes in the 
blood film in PASA may be seen as evidence of defective 
haemoglobin synthesis. However, it was the presence of free 
a 6 globin dimers in PASA reticulocytes together with the ability 
of exogenous haem to greatly stimulate PASA reticulocyte globin 
synthesis (280% increase) and restore reduced a :3 globin synthetic 
ratios towards unity (White et al, 1971; White and Ali, 1973) that 
provided the first major experimental evidence in favour of 
reduced haem synthesis in PASA. This has since been supported by 
the reports of reduced ALA synthase activity in unfractionated 
PASA bone marrow, the association between sideroblast development 
and inhibition of haem synthesis with agents such as lead and INH 
(see Bottomley, 1979, 1982), the therapeutic benefit of pyridoxine 
in some cases of congenital sideroblastic anaemia and the 
relationship between PASA and Hb H disease (Yoo et al, 1980).
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In contrast however, Peters et al (1983) found normal a:B globin 
synthetic ratios in PASA. Their failure to detect haem induced 
stimulation of PASA reticulocyte globin synthesis beyond that 
observed in normal reticulocytes has cast doubt on the earlier 
work (White et al, 1971) and its interpretation. Further doubts 
arose from the demonstration that mitochondrial iron loading and 
siderocyte formation developed in response to defective globin 
rather than defective haem synthesis in flexed-tailed mutant-(ff) 
mice (Chui et al, 1977) and from the inability of May et al 
(1982a) to clearly demonstrate deficient haem synthesis in PASA 
erythroblasts compared with age matched normal controls. The 
marked reduction in ALA synthase activity now demonstrated in the 
immature erythroblasts in PASA settles those doubts and identifies 
impaired haem synthesis as a feature of PASA.
Cytochemical staining for iron revealed erythroblast iron loading 
in all PASA percoll fractions, but more so in E3 than E^ cells. 
This does not resolve the problem as to whether reduced ALA 
synthase activity is the primary abnormality in PASA that produces 
mitochondrial iron loading (Ponka and Neuwirt, 1974; Bottomley, 
1982) or whether it occurs secondary to the toxic effect of ' 
ferric/ferrous iron on mitochondria (Hunter et al, 1963) and on 
ALA synthase itself (Morrow et al, 1969). In contrast to the more 
popular belief that PASA results from a primary defect in ALA 
synthase activity, electron microscope autoradiography has 
identified mitochondrial iron loading in PASA as the likely cause, 
not the result of reduced protein and RNA synthesis in
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sideroblasts (Wickramasinghe and Hughes, 1978). Together with the 
study of iron localisation in PASA erythroblasts this has led to 
the development of an alternative hypothesis in which a primary 
defect of iron metabolism is favoured as the cause of PASA (May et 
al, 1982a).
Iron excess certainly has adverse effects on the anaemia in PASA. 
Phlebotomy with iron reduction will improve the Hb concentration 
(Weintraub et al, 1966; Hoffbrand et al, 1974). However the 
extent to which generalised tissue iron overload contributes to 
the anaemia in PASA is unclear as the severity of the anaemia does 
not relate to the degree of tissue iron overload (Bottomley,
1982). Perhaps however the degree of mitochondrial iron overload 
is the more relevant factor.
There is no evidence from this work to support the hypothesis that 
ring sideroblasts develop as a result of reduced ALA synthase 
activity (Ponka and Neuwrit, 1974; Bottomley, 1982). The 
demonstration of reduced erythroblast ALA synthase in three cases 
of non sideroblastic anaemia (two CDA; one thalassaemia) is the 
first indication of reduced enzyme activity in conditions in'which 
ring sideroblasts are not prominent on light microscopy. It is 
clear that reduced ALA synthase activity 'per se' is not the 
obligatory cause of the readily visible ring sideroblast defect in 
PASA.
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The cause of excessive ALA synthase activity in thalassaemic 
patient 10, in whom iron overload was not present, is unclear. As 
impaired globin synthesis may be associated with an increase in 
the intracellular free haem pool (Ponka et al, 1973) it is 
possible that increased enzyme activity has resulted as proposed, 
by the action of free haem in stimulating ALA synthase activity in 
immature erythroid cells (Granick and Sassa, 1978; Sassa, 1980; 
Elder, 1981; Ibrahim et al, 1983).
CDA is a heterogeneous group of congenital anaemias which in all 
instances are associated with highly ineffective erythropoiesis 
and gross defects of DNA synthesis and nuclear morphology. Their 
pathogenesis is unclear. It is unlikely that one defect common to 
all cases could account for the three typical groups and the many 
atypical variants that have been recognised (Boogaerts and 
Verwilghen, 1982). These disorders have been associated with 
disturbed globin chain synthesis (Weatherall et al, 1973), 
secondary haemochromatosis (Cazzola et al, 1983) and in the HEMPAS 
type in particular with an increased susceptibility to lysis by 
normal sera in an acid media. Multiple red cell enzyme 
abnormalities have been described in both the congenital and'the 
acquired myelodyoplastic syndromes (Valentine et al, 1972, 1973). 
This is the first report of reduced erythroblast ALA synthase 
activity in CDA. It is hbwever unlikely that deficient haem 
synthesis is a major factor in the pathogenesis of CDA, as the 
absence of significant hypochromia indicates adequate rather than 
impaired haemoglobin formation.
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The high levels of erythroblast ALA synthase activity in 
thalassaemic patient 7 contrast with the reduced levels in 
patient 8. . Although these thalassaemia syndromes had arisen in 
response to synthetic defects affecting different globin chains it 
would seem unlikely that reduced a  chain production might 
stimulate ALA synthase, whereas reduced 8 chain production would 
inhibit ALA synthase. The most notable difference between the two 
thalassaemic patients was in their iron loading status. Patient 7 
had never received blood transfusions and was a vegetarian with 
normal serum ferritin concentration and transferrin saturation.
On the other hand, multiple blood transfusions had contributed to 
the considerable iron loading of patient 8 in whom erythroblast 
ALA synthase activity was reduced. It is likely that electron 
microscope examination of the erythroblasts from this patient, as 
with other transfused thalassaemics (Bannerman, 1964; Polliak and 
Rachmilewitz, 1973), would have uncovered considerable 
mitochondrial iron loading not visible on routine light 
microscopy. The more generalised toxic effects of iron overload 
in transfused thalassaemics are already well recognised and 
provide the stimulus behind iron chelation programmes. With 
particular respect to erythropoiesis, there is also evidence that 
iron toxicity in the thalassaemia marrow may further embarrass its 
already highly ineffective performance. Ferrokinetic studies have 
identified both the predicted immediate post transfusion 
suppression of erythropoiesis in thalassaemia major, as well as a 
long term depression resulting from repeated transfusion (Cavill 
et al, 1978). It was postulated that this effect had resulted
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from transfusional iron overload, which was already known to lead 
to mitochondrial iron loading in thalassaemia (Bannerman, 1964; 
Polliak and Rachmilewitz, 1973). This belief is supported by the 
report of reduced bone marrow ALA dehydratase and ferrochelatase 
activity in patients with thalassaemia and by the positive 
correlation between this reduction and the degree of iron loading 
as assessed by the number of blood transfusions per patient 
(Steiner et al, 1964).
Mitochondrial iron loading is then known to occur in transfusion 
dependent thalassaemia and was demonstrated at the ultrastructural 
level in both cases of CDA who, in common with thalassaemia 
patient 8, also had tissue iron overload and high transferrin 
saturation. In the three patients with PASA mitochondrial iron 
loading was readily visible on light microscopy but had developed 
in two of these cases in the absence of tissue iron overload or 
increased transferrin saturation. In these three PASA patients 
there was no evidence of reduced ALA synthase activity in the bone 
marrow myeloid cells (Section 4.5), which although probably the 
product of the same sideroblastic marrow clone (Prchal et al,
1978) do not show mitochondrial iron loading (Larizza and Orlandi, 
1964). Erythroblast mitochondrial iron loading appears to be the 
only common factor shared by the six patients with reduced 
erythroblast ALA synthase activity.
Therefore it is postulated that in all six cases reduced enzyme 
activity was due to iron-mediated inhibition of ALA synthase
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activity and abnormal erythroblast iron metabolism. In CDA and 
transfused thalassaemia it is likely that reduced enzyme activity 
developed as a result of erythroblast iron overload occurring 
secondary to tissue iron overload and high transferrin 
saturation. In contrast, the abnormalities in PASA developed even 
in the absence of tissue iron overload and high transferrin 
saturation. It is then postulated that reduced ALA synthase 
activity in PASA reflects mitochondrial iron toxicity which has 
resulted from a primary abnormality of erythroblast iron 
metabolism.
It is further possible to postulate the way in which iron inhibits 
ALA synthase activity. The major deficiency of ALA synthase in 
PASA was in the early erythroblasts, whereas maximum visible iron 
deposits were seen in the late erythroblasts, in which enzyme 
activity was not significantly lower than in the normoblastic late 
erythroblasts. This would suggest that reduced enzyme activity 
does not result from gross visible mitochondrial iron deposits, 
but presumably from a metabolically active "iron pool", which 
although not visible to the eye or electron microscopy, may be 
toxic and promote free radical damage. As maximum inhibition of 
ALA synthaseby an invisible iron pool might reasonably be 
expected to correlate with maximal iron uptake, this hypothesis is 
supported by the findings of Hodgetts et al (1986), who using TG-1 
and percoll marrow fractionation as described, identified maximum 
iron uptake in the early erythroblasts of percoll fractions 1 
and 2.
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SUMMARY TO CHAPTER 5
ALA synthase activity has been measured in the progressive stages 
of human erythroblast differentiation. Enzyme activity was 
fourfold higher in pro and early basophilic erythroblasts than in 
late orthochromatic forms. Markedly reduced erythroblast ALA 
synthase activity was found in six patients with three dissimilar 
conditions: three PASA, 2 CDA and one case of iron loaded 
thalassaemia. Reduced ALA synthase activity was not found in one 
thalassaemia patient without iron loading.
Erythroblast mitochondrial iron loading is known to occur 
following frequent transfusions in thalassaemia. It was 
demonstrated by light microscopy in PASA and by electron 
microscopy in CDA and was identified as the one relevant factor 
common to all six patients.
Therefore it is postulated that reduced erythroblast ALA .synthase 
activity results from abnormal erythroblast iron metabolism, which 
may occur secondary to tissue iron overload and high transferrin 
saturation in CDA and transfused thalassaemia, but as a primary 
abnormality of erythroblast iron metabolism in PASA.
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CHAPTER 6
CONCLUSIONS
6 . CONCLUSIONS
The myelodysplastic syndromes (MDS) represent a clonal abnormality 
of the haemopoietic stem cell with a high probability of eventual 
acute leukaemic transformation. Although PASA represents a 
distinct entity in the FAB classification of MDS proposed by 
Bennett et al (1982) there is remarkable similarity between the 
different MDS groups with respect to clonal assays and 
ferrokinetic parameters (May et al, 1985). Indeed a diagnosis of 
"sideroblastic anaemia" as an anaemia with more than 15% ring 
sideroblasts has to be seen in the context of a wide range of 
sideroblast counts in patients with MDS from 1-86% (May et al, 
1982a; Juneja et al, 1983; May et al, 1985). It is not known if 
similarities in MDS extend to a reduction in erythroblast ALA 
synthase activity as seen in PASA.
One patient with a non sideroblastic MDS, without tissue iron 
overload, has been studied. The patient was a 26 year old male 
with unexplained acquired pancytopenia (Hb 9.1 g/dl WC 3.0 x 10^/1 
platelets 100 x 10^/1) and ferrokinetic evidence of 90% 
ineffective erythropoiesis. There was no past history of 
anaemia. Serum ferritin was 26 ug/1 and transferrin saturation 
25%. Erythroblast ALA synthase activity was normal (Fig 23).
This might then indicate that reduced ALA synthase activity is not 
a feature common to all MDS and is confined to such cases that are 
associated with prominent mitochondrial iron loading.
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Figure 23
The work reported in this thesis is the first of its kind as no 
previous studies have examined haem biosynthesis in age matched 
"in vivo" human erythroblasts. It has also shown that ALA 
synthase activity as measured in unfractionated human bone marrow 
reflects activity present in both myeloid and erythroid cells and 
is insensitive to the changes in erythroblast ALA synthase that 
occur during differentiation. There is then the need to 
reappraise all previous studies made on unfractionated bone 
marrow, which without exception, have reported their results as a 
measure of erythroblast ALA synthase activity. Further studies of 
haem biosynthesis in human bone marrow are required but should in 
future clearly and separately define the separate contributions 
made by myeloid and erythroid cells using suitably sensitive 
enzyme assay techniques.
The nature of the work has limited the number of patients studied 
and a first priority for further experiments would be to extend 
the number of observations already made. At present however there 
seems to be sufficient evidence to dispel the theory that reduced 
erythroblast ALA synthase activity is the primary abnormality in 
PASA (Aoki et al, 1974; Ponka and Neuwirt, 1974; Bottomley, 1977, 
1982). Reduced erythroblast ALA synthase activity was found in 
CDA and thalassaemia, in addition to PASA, thereby indicating that 
reduced enzyme activity does not "per se" cause readily visible 
mitochondrial iron loading. Furthermore the failure to detect 
reduced myeloid cell ALA synthase activity in PASA bone marrow 
(Chapter 4) lessens the likelihood of there being a generalised 
primary defect of mitochondrial function as well as ALA synthase 
activity in PASA as proposed by Aoki (1980).
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The most significant contribution made by this work has been its 
demonstration that we now have the ability to unveil the secrets 
of human erythroblast haem biosynthesis (see Chapter 1) and need 
no longer rely on the study of foetal erythropoiesis or "in vitro" 
erythroid cell cultures for information on haem synthesis, which 
by inference may also apply to the "in vivo" human situation. By 
combining a suitably sensitive assay of ALA synthase activity with 
bone marrow fractionation, enzyme activity was directly measured 
in differentiating "in vivo" erythroblasts, recovered at 
particular stages of development in percoll fractions containing 
age matched erythroblasts. The natural progression from this 
initial step would be to examine the activities of the other haem 
enzymes and establish the complete synthetic sequence from 
appearance to maximal activity for each individual enzyme during 
differentiation. Human erythroblasts and in particular early and 
pro erythroblasts, may now also take the place of rabbit 
reticulocytes and FEL cells to study the primary effects of INH 
and succinylacetone on erythroblast haem synthesis and their 
secondary effects on iron and protein metabolism and erythroblast 
differentiation. Lastly, as bone marrow fractionation is the only 
means by which pathological age matched erythroblasts may be, 
obtained, haem synthetic enzyme activity may now be examined in 
secondary anaemias, iron deficiency/overload and myelodysplastic 
states .
The final section in Chapter 1 discussed the curious paradox 
apparent in the suggestion that while reduced activity of a haem
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biosynthetic enzyme may cause PASA, anaemia is an uncommon 
manifestation of porphyria. This paradox is resolved by the 
proposal that reduced ALA synthase activity in the different 
erythroblasts studied resulted from iron toxicity mediated within 
the mitochondria and that reduced ALA synthase activity is not the 
cause of ring sideroblast development. It is likely that reduced 
haem synthesis contributes significantly to the anaemia in PASA 
but more so as a consequence of disturbed erythroblast iron 
metabolism than as a result of reduced ALA synthase activity.
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APPENDIX 1
GENERAL METHODS
Appendix 1. GENERAL METHODS
1. ROUTINE HAEMATOLOGICAL PARAMETERS
The measurement of haemoglobin concentration and red cell indices 
was performed on a Coulter Counter Model S. Serum iron, TIBC was 
determined by the standard colorimetric methods serum ferritin 
concentration by immunoradiometric assay and serum Vit B]_2 and 
folate levels by radioassay (Becton Dickinson)•
2. CULTURE MEDIUM
Culture medium contained Eagles MEM, buffered with 20 mM Hepes to 
pH 7.4 at 37°C, with glycine 1 mM. This was prepared in 500 ml 
aliquots; 90 ml was removed from a 500 ml bottle of sterile 
distilled water to which 50 ml Eagles MEM (x 10 concentrated),
10 ml Hepes (Gibco) 1 M pH 7.3, 4 ml 1 N NaOH and 3 ml glycine 
20 mg/ml were added.
3. BONE MARROW COLLECTING MEDIUM
Bone marrow samples were collected into culture medium containing 
25% (v/v) heat inactivated foetal calf serum (Gibco) and 
preservative free heparin 15 U/ml.
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4. BONE MARROW CELL COUNTS AND CYTOSPIN PREPARATIONS
Cell counts were made using a Coulter Counter Model ZF fitted with 
a channeliser attachment.
Bone marrow cells were washed x 3 in cold culture medium. Heat 
inactivated foetal calf serum, filtered through 0.22 jam micropore 
filter, was added to the bone marrow cells to achieve a final 
concentration of 2 x 10  ^nucleated cells per ml. 0.25 ml was 
added to clean cytospin holders in a Shandon Southern 
cytocentrifuge. Centrifugation was at 600 rpm for 10 minutes.
Cell morphology was optimally preserved at 5 x 10^ nucleated cells 
per slide.
s
5. BONE MARROW SAMPLES
The study was approved by the South Glamorgan Joint Ethics 
Committee. All patients gave their fully informed written consent.
For the development of the ALA synthase assay, bone marrow was 
obtained from ribs resected at thoracatomy or by curetting the cut 
surface of the sternum following sternotomy for cardiothoracic 
surgical procedures. In all cases the peripheral blood counts and 
bone marrow morphology was normal.
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6. STAINING PROCEDURES
Morphological examination of marrow cells was made on cytospin 
preparation stained with Jenner Geimsa stain. Cytochemical 
.staining for iron was made by Peris stain.
7. REFRIGERATED CENTRIFUGES
Two refrigerated centrifuges were used throughout, an MSE 2L and ' 
an MSE, Mistral 3000 refrigerated bench centrifuge.
8. ALA SYNTHASE ASSAY
(a) Incubation medium
Incubation medium for use with 2-keto [^^C]glutarate was that as 
described by Tikerpae et al (1981) and contained glycine 50 mM, 
sucrose 250 mM, MgCl£ 5 mM, EDTA 10 mM, PLP 0.4 mM CoA 0.25 mM, 
Tris 40 mM buffered to pH 7.4 with KH2 PO4 50 mM.
All incubation media were prepared to pH 7.4 at 37°C as determined 
by the blood gas analyser in the Department of Medical 
Biochemistry.
(b) Radiochemicals
Radiochemicals were purchased from Amersham International pic.
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\2-keto 5-[^C]glutaric acid, sodium salt, was freeze
dried and stored under nitrogen at -20°C. It was prepared to 
1.7 mM (specific activity 6 Ci/mol) in incubation medium on the 
day of assay and used in the reaction at a final concentration of
20 mM succinate (specific activity 3.0 Ci/mol) in the basic 
incubation medium of Tikerpae et al (1981) to which PLP, CoA, 
succinylacetone, STK and GTP were added on the day of assay.
in 50 ul aliquots of 0.25 mM ALA (0.5 uCi/50 ul, specific activity 
40 Ci/m mol).
9. MODIFIED EHRLICHS REAGENT
Modified Ehrlichs reagent was prepared fresh daily by dissolving 
1 g p - DMAB in 30 ml glacial acetic acid. 8 ml 70% perchloric 
acid,was added and the final volume made up to 50 ml with glacial 
acetic acid (Falk, 1964).
10. METHANOL EVAPORATION
ALA pyrrole, eluted from the Sep-pak cartridge (Waters 
associates), was evaporated to dryness under nitrogen in a Techne 
Dri Block-3 sample concentrator at 35°C.
0.17 mM.
2,3- 'uccinic acid was stored at -20°C in 210 ul aliquots of
5-amino 4-[^^C] laevulinic acid hydrochloride was stored at -20°C
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11. RPHPLC
The HPLC system consisted of a dual piston Waters M 6000 A pump, 
set at flow rate 1.5 ml/min with a Rheodyne 7125 sample injector 
fitted with a 50 ul loop.
Mobile phase contained 35% (v/v) aqueous methanol with 0.005 M 
heptane sulphonic acid (PIC B-7, Waters Associates) as ion pairing 
agent. Mobile phase was filtered (micropore 0.45 mm filter) 
before use.
Two reverse phase HPLC columns (4.6 x 150 mm) were used. One was 
an Ultrasphere Cl8 ODS ion pairing column; the other an Apex Cl8 
0DS column.
An LDC Spectro Monitor 111 was used at 252 nm and 1.0 AUFS to 
detect eluted ALA pyrrole. Column fractions were collected in 
scintillation vials at 30 sec intervals.
12. SCINTILLATION FLUID
Two interchangeable scintillation fluids were used throughout.
The initial scintillant used was prepared from toluene (1 1), 
Triton (500 ml), PPO (4 g) and POPOP (0.1 g). This solution was 
left to stir overnight and maintained in the dark for 1 hour 
before use. In later experiments Liquiscint (National Diagnotics) 
was used.
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13. SCINTILLATION COUNTING
All samples for counting contained 0.75 ml of the mobile phase 
used for HPLC. This was equivalent to the volume collected in 
30 second fractions from HPLC and ensured a similar level of 
quenching in the radioactive standards and HPLC samples. The 
ratio of mobile phase to scintillant was 1:10.
A Rack Beta scintillation counter was used. Quenching was 
measured using the channels ratio method. This was uniform 
indicating that counting efficiency was the same for all tubes. 
As such it was not necessary to convert cpm to dpm.
14. STATISTICS
Unless otherwise stated statistical analysis of results was 
carried out using the students t test.
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